<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="sps-1.9" dtd-version="1.1" xml:lang="pt" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
        <publisher-loc>S&#227;o Paulo, SP, Brazil</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">bwM3p6npTvzBxc4rjyxcL8N</article-id>
      <article-id pub-id-type="other">00004</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2010001600004</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v1">S0066-782X(10)09500604</article-id>
      <article-id pub-id-type="doi">10.1590/S0066-782X2010005000151</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Artigos Originais</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Qualidade de vida em pacientes com doen&#231;a aterocler&#243;tica coronariana grave e est&#225;vel</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Moriel</surname>
            <given-names>Gisele</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Roscani</surname>
            <given-names>Meliza Goi</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Matsubara</surname>
            <given-names>Luiz Shiguero</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cerqueira</surname>
            <given-names>Ana Teresa de A. Ramos</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Matsubara</surname>
            <given-names>Beatriz Bojikian</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
      </contrib-group>
      <aff id="aff01">
        <addr-line>
          <named-content content-type="state"/>
        </addr-line>
        <institution content-type="orgname">Hospital de Santa Marcelina</institution>
        <country country="BR">Brazil</country>
      </aff>
      <aff id="aff02">
        <addr-line>
          <named-content content-type="city">S&#227;o Paulo</named-content>
          <named-content content-type="state">S&#227;o Paulo</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade Estadual Paulista</institution>
        <institution content-type="orgdiv1">Faculdade de Medicina de Botucatu </institution>
        <country country="BR">Brazil</country>
      </aff>
      <pub-date date-type="collection" publication-format="electronic">
        <month>12</month>
        <year>2010</year>
      </pub-date>
      <volume>95</volume>
      <issue>6</issue>
      <fpage>691</fpage>
      <lpage>697</lpage>
      <history>
        <date date-type="rev-recd">
          <day>17</day>
          <month>06</month>
          <year>2010</year>
        </date>
        <date date-type="received">
          <day>22</day>
          <month>11</month>
          <year>2009</year>
        </date>
        <date date-type="accepted">
          <day>15</day>
          <month>07</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" xml:lang="en">
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>FUNDAMENTO: Existem poucas informa&#231;&#245;es sobre fatores agravantes da qualidade de vida em pacientes com doen&#231;a arterial coronariana (DAC), antes da interven&#231;&#227;o coron&#225;ria percut&#226;nea (ICP). OBJETIVO: Associar vari&#225;veis cl&#237;nicas com escores de qualidade de vida (EQV) em pacientes com DAC est&#225;vel, antes da ICP e com desfechos desfavor&#225;veis, 12 meses ap&#243;s o procedimento. M&#201;TODOS: Trata-se de estudo longitudinal incluindo 78 pacientes (43 homens e 35 mulheres), antes da ICP eletiva. As associa&#231;&#245;es entre EQV (question&#225;rio SF-36) e idade, sexo, peso, &#237;ndice de massa corp&#243;rea, diabete melito (DM), hipertens&#227;o arterial, dislipidemia, tabagismo atual, evento cardiovascular ou ICP pr&#233;vios, controle da glicemia e da press&#227;o arterial foram analisadas por meio de regress&#227;o log&#237;stica multivariada. Tamb&#233;m se analisaram as associa&#231;&#245;es entre esses atributos cl&#237;nicos e os desfechos desfavor&#225;veis (morte por qualquer causa, insufici&#234;ncia card&#237;aca ou infarto n&#227;o fatal). O n&#237;vel de signific&#226;ncia foi p &lt; 0,05. RESULTADOS: As medianas dos EQV estiveram abaixo de 70 percentuais em todos os dom&#237;nios. Sexo feminino, idade &lt; 60 anos, evento cardiovascular ou ICP pr&#233;vios, IMC &gt; 25 kg/m&#178;, DM e press&#227;o arterial elevada foram associados a maior preju&#237;zo de, pelo menos, um dos EQV. Sexo feminino (OR: 7,19; IC95%: 1,55 - 33,36; p = 0,012), evento cardiovascular pr&#233;vio (OR: 3,97; IC95%: 1,01 - 15,66; p = 0,049) e insucesso na ICP (OR: 10,60; IC95%: 1,83 - 61,46; p = 0,008) foram associados com risco aumentado de desfecho combinado. CONCLUS&#195;O: Na presen&#231;a de DAC, mulheres e pacientes com comorbidades t&#234;m maior preju&#237;zo da qualidade de vida. Os desfechos desfavor&#225;veis ap&#243;s 12 meses da ICP est&#227;o associados com o sexo feminino, evento pr&#233;vio ou insucesso do procedimento.</p>
      </abstract>
      <kwd-group xml:lang="pt" kwd-group-type="author-generated">
        <kwd>Qualidade de vida</kwd>
        <kwd>depress&#227;o</kwd>
        <kwd>doen&#231;a da art&#233;ria coronariana</kwd>
        <kwd>mulheres</kwd>
      </kwd-group>
      <pub-date publication-format="electronic" date-type="pub">
        <day>19</day>
        <month>11</month>
        <year>2010</year>
      </pub-date>
    </article-meta>
  </front>
  <body>
    <p>
      <bold>ARTIGO ORIGINAL</bold>
    </p>
    <p>
      <bold>Qualidade de vida em pacientes com doen&#231;a aterocler&#243;tica coronariana grave e est&#225;vel</bold>
    </p>
    <p>
      <bold>Gisele Moriel<sup>I</sup>; Meliza Goi Roscani<sup>II</sup>; Luiz Shiguero Matsubara<sup>II</sup>; Ana Teresa de A. Ramos Cerqueira<sup>II</sup>; Beatriz Bojikian Matsubara<sup>II</sup></bold>
    </p>
    <p><sup>I</sup>Hospital Santa Marcelina S&#227;o Paulo, SP - Brasil </p>
    <p><sup>II</sup>Faculdade de Medicina de Botucatu - UNESP S&#227;o Paulo, SP - Brasil</p>
    <p>
      <xref ref-type="corresp" rid="back">Correspond&#234;ncia</xref>
    </p>
    <p>
      <bold>RESUMO</bold>
    </p>
    <p><bold>FUNDAMENTO: </bold> Existem poucas informa&#231;&#245;es sobre fatores agravantes da qualidade de vida em pacientes com doen&#231;a arterial coronariana (DAC), antes da interven&#231;&#227;o coron&#225;ria percut&#226;nea (ICP). </p>
    <p><bold>OBJETIVO: </bold> Associar vari&#225;veis cl&#237;nicas com escores de qualidade de vida (EQV) em pacientes com DAC est&#225;vel, antes da ICP e com desfechos desfavor&#225;veis, 12 meses ap&#243;s o procedimento. </p>
    <p><bold>M&#201;TODOS: </bold> Trata-se de estudo longitudinal incluindo 78 pacientes (43 homens e 35 mulheres), antes da ICP eletiva. As associa&#231;&#245;es entre EQV (question&#225;rio SF-36) e idade, sexo, peso, &#237;ndice de massa corp&#243;rea, diabete melito (DM), hipertens&#227;o arterial, dislipidemia, tabagismo atual, evento cardiovascular ou ICP pr&#233;vios, controle da glicemia e da press&#227;o arterial foram analisadas por meio de regress&#227;o log&#237;stica multivariada. Tamb&#233;m se analisaram as associa&#231;&#245;es entre esses atributos cl&#237;nicos e os desfechos desfavor&#225;veis (morte por qualquer causa, insufici&#234;ncia card&#237;aca ou infarto n&#227;o fatal). O n&#237;vel de signific&#226;ncia foi p &lt; 0,05. </p>
    <p><bold>RESULTADOS:</bold> As medianas dos EQV estiveram abaixo de 70 percentuais em todos os dom&#237;nios. Sexo feminino, idade &lt; 60 anos, evento cardiovascular ou ICP pr&#233;vios, IMC <underline>&gt;</underline> 25 kg/m&#178;, DM e press&#227;o arterial elevada foram associados a maior preju&#237;zo de, pelo menos, um dos EQV. Sexo feminino (OR: 7,19; IC<sub>95%</sub>: 1,55 - 33,36; p = 0,012), evento cardiovascular pr&#233;vio (OR: 3,97; IC<sub>95%</sub>: 1,01 - 15,66; p = 0,049) e insucesso na ICP (OR: 10,60; IC<sub>95%</sub>: 1,83 - 61,46; p = 0,008) foram associados com risco aumentado de desfecho combinado. </p>
    <p><bold>CONCLUS&#195;O: </bold> Na presen&#231;a de DAC, mulheres e pacientes com comorbidades t&#234;m maior preju&#237;zo da qualidade de vida. Os desfechos desfavor&#225;veis ap&#243;s 12 meses da ICP est&#227;o associados com o sexo feminino, evento pr&#233;vio ou insucesso do procedimento. </p>
    <p><bold>Palavras-chave: </bold> Qualidade de vida, depress&#227;o, doen&#231;a da art&#233;ria coronariana, mulheres.</p>
    <p>
      <bold>Introdu&#231;&#227;o</bold>
    </p>
    <p>Estilo de vida e estresse emocional s&#227;o fatores de risco para doen&#231;as cardiovasculares que t&#234;m merecido destaque na literatura. Estudos mostraram uma maior incid&#234;ncia de eventos cardiovasculares na popula&#231;&#227;o com sintomas depressivos ou baixos escores de indicadores de qualidade de vida. Al&#233;m disso, pacientes com doen&#231;a ateroscler&#243;tica coronariana (DAC) j&#225; instalada apresentam qualidade de vida prejudicada e n&#237;vel elevado de estresse, impostos pela pr&#243;pria condi&#231;&#227;o de doen&#231;a, limita&#231;&#227;o f&#237;sica e risco de morte, fechando um c&#237;rculo vicioso que intensifica a progress&#227;o da doen&#231;a<sup>1-4</sup>. Presume-se que, al&#233;m da gravidade da doen&#231;a, a associa&#231;&#227;o de comorbidades, como diabete melito (DM), hipertens&#227;o arterial (HA) e obesidade, frequentemente presentes nesses pacientes, poderia representar uma agravante no decl&#237;nio da qualidade de vida<sup>5</sup>.</p>
    <p>A defini&#231;&#227;o global de qualidade de vida leva em conta as condi&#231;&#245;es externas de vida e as experi&#234;ncias subjetivas do indiv&#237;duo<sup>6</sup>. N&#227;o &#233; tarefa f&#225;cil quantificar qualidade de vida. Para tanto, existem v&#225;rias propostas de instrumentos que foram validados por diversos estudos. A avalia&#231;&#227;o do estado de sa&#250;de pelo Question&#225;rio de Angina de Seattle (QAS)<sup>7</sup> &#233; uma metodologia utilizada para avaliar qualidade de vida relacionada &#224;s limita&#231;&#245;es nas atividades di&#225;rias proporcionadas pela intensidade da angina, bem como a satisfa&#231;&#227;o com o tratamento realizado. Um question&#225;rio mais abrangente e mais bem aplicado a pacientes com doen&#231;as cr&#244;nicas, incluindo a DAC &#233; o <italic>Medical Outcomes Study 36-item Short-form Health Survey (SF-36)</italic><sup>1,8-10</sup>, traduzido e validado no Brasil<sup>11</sup>.</p>
    <p>Norris e cols.<sup>12</sup> avaliaram 3.392 pacientes com DAC, um ano ap&#243;s estudo hemodin&#226;mico, utilizando o question&#225;rio QAS, e observaram que as mulheres, em rela&#231;&#227;o ao sexo masculino, apresentaram preju&#237;zo nos &#237;ndices de qualidade de vida em v&#225;rios quesitos, tais como: menor satisfa&#231;&#227;o com o tratamento realizado, maior frequ&#234;ncia dos epis&#243;dios de angina e menor capacidade para exerc&#237;cio f&#237;sico.</p>
    <p>Outro estudo<sup>13</sup> mostrou que mulheres acima de 65 anos e com sintomas depressivos apresentavam evolu&#231;&#227;o cl&#237;nica desfavor&#225;vel, com pior progn&#243;stico, 6 meses ap&#243;s evento cardiovascular.</p>
    <p>Em nosso meio, Favarato e cols.<sup>14</sup> descreveram preju&#237;zo mais acentuado da qualidade de vida em mulheres com DAC, ap&#243;s tratamento cl&#237;nico, cir&#250;rgico ou ICP, quando comparadas aos homens. Esses resultados foram consistentes com o estudo Rita-2<sup>15</sup>, que incluiu casu&#237;stica numerosa e que tamb&#233;m identificou o g&#234;nero feminino como fator associado &#224; piora da qualidade de vida em pacientes com DAC.</p>
    <p>Uma vez que a literatura nacional &#233; pobre em informa&#231;&#245;es sobre tal aspecto, o objetivo do presente estudo foi associar vari&#225;veis cl&#237;nicas e escores de qualidade de vida (EQV) em pacientes com DAC grave e est&#225;vel, antes da ICP, e avaliar desfechos desfavor&#225;veis, 12 meses ap&#243;s procedimento.</p>
    <p>
      <bold>M&#233;todos</bold>
    </p>
    <p>Todos os procedimentos foram submetidos &#224; aprecia&#231;&#227;o, sendo aprovados pelo Comit&#234; de &#201;tica em Pesquisa da Faculdade de Medicina de Botucatu - UNESP (OF.78/2005-CEP). N&#227;o houve fontes de financiamento para esta pesquisa.</p>
    <p>Foi realizado estudo prospectivo longitudinal em uma popula&#231;&#227;o de pacientes encaminhados para realizar ICP.</p>
    <p>Foram inclu&#237;dos 78 pacientes de ambos os sexos, maiores de 18 anos e sem outros limites de idade, com diagn&#243;stico de DAC, independente de diagn&#243;stico pr&#233;vio de infarto agudo do mioc&#225;rdio (IAM) e submetidos &#224; angioplastia de uma ou mais art&#233;rias coron&#225;rias, em procedimento eletivo e agendado com anteced&#234;ncia. Todos concordaram em participar e assinaram o termo de consentimento livre e esclarecido. Esses pacientes foram encaminhados pelos ambulat&#243;rios regionais de cardiologia, no per&#237;odo de agosto de 2004 a junho de 2006. Todos os pacientes passaram por avalia&#231;&#227;o cl&#237;nica cardiol&#243;gica completa.</p>
    <p>Foram adotados os seguintes crit&#233;rios de exclus&#227;o: 1) instabilidade hemodin&#226;mica, caracterizada por press&#227;o sist&#243;lica menor de que 100 mmHg e/ou dispneia de repouso, dor precordial no momento da avalia&#231;&#227;o, arritmias graves; 2) pacientes com diagn&#243;stico de s&#237;ndrome isqu&#234;mica aguda.</p>
    <p>
      <bold>Avalia&#231;&#227;o cl&#237;nica</bold>
    </p>
    <p>As vari&#225;veis demogr&#225;ficas e cl&#237;nicas foram: proced&#234;ncia, situa&#231;&#227;o conjugal, sexo, escolaridade, situa&#231;&#227;o em rela&#231;&#227;o &#224; ocupa&#231;&#227;o, idade, hist&#243;ria pr&#233;via de IAM ou outro evento cardiovascular (s&#237;ndrome isqu&#234;mica aguda, doen&#231;a arterial perif&#233;rica, ou acidente vascular encef&#225;lico), diabete melito, hipertens&#227;o arterial ou tabagismo, n&#250;mero de art&#233;rias coron&#225;rias com les&#227;o grave (&gt; 70% de obstru&#231;&#227;o da luz), peso, altura, &#237;ndice de massa corp&#243;rea, press&#227;o arterial. Ap&#243;s a angioplastia, foram consideradas as seguintes vari&#225;veis: art&#233;ria coron&#225;ria submetida ao procedimento e resultado da angioplastia (o sucesso no procedimento foi definido como fluxo TIMI 3 na art&#233;ria submetida &#224; ICP).</p>
    <p>As vari&#225;veis laboratoriais foram: glicemia de jejum, colesterol total e fra&#231;&#245;es, triglic&#233;rides, ureia, creatinina s&#233;rica, hemat&#243;crito e hemoglobina.</p>
    <p>Foram adotados os seguintes valores para defini&#231;&#227;o de controle dos fatores de risco: press&#227;o arterial sist&#243;lica &lt; 140 mmHg e diast&#243;lica &lt; 90 mmHg (em pacientes diab&#233;ticos, esses valores foram reduzidos para 130 e 80 mmHg, respectivamente); glicemia de jejum <underline>&lt;</underline> 126 mg/dl; LDL-colesterol <underline>&lt;</underline> 100 mg/dl; IMC &lt; 25 kg/m&#178;; e triglic&#233;rides <underline>&lt;</underline> 150 mg/dl<sup>13,16,17</sup>.</p>
    <p>
      <bold>Avalia&#231;&#227;o da qualidade de vida</bold>
    </p>
    <p>Foi aplicado o question&#225;rio padr&#227;o SF-36, sempre pela mesma entrevistadora, nas depend&#234;ncias do HC, em sala especificamente destinada para este fim, em ambiente calmo, silencioso e privativo. Esse instrumento cont&#233;m 36 itens que englobam 8 dom&#237;nios: capacidade funcional (10 itens); desempenho f&#237;sico (4 itens); dor (2 itens); estado geral de sa&#250;de (5 itens); vitalidade (4 itens); aspectos sociais (2 itens); aspectos emocionais (3 itens); e sa&#250;de mental (5 itens). A partir das respostas obtidas, foram calculados os escores de qualidade de vida, segundo a recomenda&#231;&#227;o da literatura<sup>6,7,18</sup>.</p>
    <p>As medianas dos valores dos escores foram tomados como refer&#234;ncia para categoriza&#231;&#227;o dos escores "maiores" e "menores", em cada aspecto.</p>
    <p>
      <bold>Desfechos cl&#237;nicos</bold>
    </p>
    <p>Ap&#243;s 12 meses da realiza&#231;&#227;o da angioplastia, foram realizados contatos por telefone e consultas aos prontu&#225;rios m&#233;dicos para o registro de desfechos. Foram considerados como "desfechos cl&#237;nicos desfavor&#225;veis": &#243;bito por qualquer causa, interna&#231;&#227;o por insufici&#234;ncia card&#237;aca (IC) ou IAM n&#227;o fatal.</p>
    <p>
      <bold>An&#225;lise estat&#237;stica</bold>
    </p>
    <p>Foram calculados os valores m&#233;dios, com os respectivos desvios-padr&#227;o para vari&#225;veis cont&#237;nuas e com distribui&#231;&#227;o normal. Os EQV foram expressos como medianas e amplitudes interquart&#237;licas. A an&#225;lise explorat&#243;ria univariada foi efetuada por meio dos testes "t" de <italic>student</italic> ou de Mann-Whitney. As diferen&#231;as entre propor&#231;&#245;es foram analisadas pelo teste do qui-quadrado. As associa&#231;&#245;es com probabilidade menor de que 0,20 de serem devidas ao acaso foram introduzidas no modelo de regress&#227;o log&#237;stica multivariada.</p>
    <p>A an&#225;lise de regress&#227;o log&#237;stica multivariada foi aplicada para identificar quais atributos cl&#237;nicos estiveram associados a preju&#237;zo dos EQV categorizados. Nessa an&#225;lise, assumiu-se como vari&#225;vel dependente a categoria "maior" ou "menor", em cada um dos 8 quesitos estudados. As seguintes vari&#225;veis independentes foram categorizadas e inclu&#237;das no modelo: sexo (masculino e feminino), idade (<underline>&gt;</underline> 60 anos ou &lt; 60 anos), IMC (&lt; 25 kg/m&#178; ou <underline>&gt;</underline> 25 kg/m&#178;), diabete melito (sim/n&#227;o), glicemia de jejum aumentada (sim/n&#227;o), evento cardiovascular pr&#233;vio (sim/n&#227;o), angioplastia pr&#233;via (sim/n&#227;o), tabagismo atual (sim/n&#227;o). Tamb&#233;m foram inclu&#237;das as seguintes vari&#225;veis cont&#237;nuas: press&#227;o arterial sist&#243;lica (PAS) e press&#227;o arterial diast&#243;lica (PAD).</p>
    <p>A mesma an&#225;lise foi efetuada para identificar quais atributos cl&#237;nicos foram associados com desfecho cl&#237;nico combinado.</p>
    <p>Em todos os casos, o n&#237;vel de signific&#226;ncia adotado foi p &lt; 0,05.</p>
    <p>
      <bold>Resultados</bold>
    </p>
    <p>Trinta e cinco pacientes da casu&#237;stica estudada eram do sexo feminino e 43 do sexo masculino. Na <xref ref-type="table" rid="t1">Tabela 1</xref>, s&#227;o apresentados as m&#233;dias e os desvios-padr&#227;o da idade, peso, altura, press&#227;o arterial e vari&#225;veis bioqu&#237;micas. A distribui&#231;&#227;o dos EQV est&#225; ilustrada na <xref ref-type="fig" rid="f1">Figura 1</xref>. As medianas e os intervalos interquart&#237;licos dos escores nos 8 dom&#237;nios foram: 65; 40-85 (capacidade funcional); 25, 0-50 (aspectos f&#237;sicos); 52, 30-72 (dor); 62, 47-77 (estado geral de sa&#250;de); 62, 45-75 (vitalidade); 50, 37-100 (aspectos sociais); 67, 33-100 (aspectos emocionais); e 66, 40-80 (sa&#250;de mental).</p>
    <table-wrap id="t1">
      <graphic xlink:href="1678-4170-abc-95-06-0691-00151-gt01.jpg"/></table-wrap>
    <fig id="f1">
      <graphic xlink:href="1678-4170-abc-95-06-0691-00151-gf01.jpg"/></fig>
    <p>Na <xref ref-type="table" rid="t2">Tabela 2,</xref> s&#227;o apresentados as medianas e os percentis 25 e 75 dos escores dos 8 dom&#237;nios que comp&#245;em o SF-36, nos homens e mulheres.</p>
    <table-wrap id="t2">
      <graphic xlink:href="1678-4170-abc-95-06-0691-00151-gt02.jpg"/></table-wrap>
    <p>As associa&#231;&#245;es significantes entre os diversos aspectos dos EQV e as vari&#225;veis cl&#237;nicas foram:</p>
    <p><italic>1. Capacidade funcional -</italic> idade <underline>&gt;</underline> 60 anos (OR: 0,18; IC<sub>95%</sub>: 0,05 a 0,72; p = 0,04) e sexo masculino (OR: 0,18; IC<sub>95%:</sub> -3,0 a -0,44; p = 0,009) foram fatores de prote&#231;&#227;o reduzindo o risco de preju&#237;zo de EQV. PAS mais elevada (143 &#177; 23 mmHg <italic>vs</italic> 133 &#177; 16 mmHg; p = 0,032) e IMC &gt; 25 kg/m&#178; foram associados a escores mais baixos (OR: 1,05; IC<sub>95%</sub>: 0,01-0,09; p = 0,01 e OR: 3,8; IC<sub>95%</sub>: 1,06-13,8; p = 0,04, respectivamente).</p>
    <p><italic>2. Aspectos f&#237;sicos -</italic> a &#250;nica vari&#225;vel associada de forma independente a menor EQV foi a presen&#231;a de evento cardiovascular pr&#233;vio (OR: 3,7; IC<sub>95%</sub>: 1,2-11,4; p = 0,02).</p>
    <p><italic>3. Dor -</italic> somente o sexo masculino mostrou-se como fator protetor e associado a escores maiores neste quesito (OR: 0,26; IC<sub>95%</sub>: 0,08-0,78; p = 0,017).</p>
    <p><italic>4. Estado geral de sa&#250;de -</italic> a presen&#231;a de DM e evento cardiovascular pr&#233;vio foram associados de forma significante ao preju&#237;zo adicional da qualidade de vida (OR: 11,2; IC<sub>95%</sub>: 1,29-97,8; p = 0,028 e OR: 5,6; IC<sub>95%</sub>: 1,4-22,7; p = 0,015, respectivamente).</p>
    <p><italic>5. Vitalidade -</italic> nenhuma das vari&#225;veis inclu&#237;das no modelo de regress&#227;o log&#237;stica foi associada de forma independente com preju&#237;zo adicional do escore, na amostra estudada.</p>
    <p><italic>6. Aspectos sociais -</italic> ICP pr&#233;via foi associada com escores menores (OR: 10,3; IC<sub>95%</sub>5: 3,9-33,1; p = 0,001).</p>
    <p><italic>7. Aspectos emocionais -</italic> n&#227;o se identificou qualquer vari&#225;vel cl&#237;nica contribuindo de forma significante para a modifica&#231;&#227;o deste escore.</p>
    <p><italic>8. Sa&#250;de mental -</italic> sexo masculino foi associado com menor risco de redu&#231;&#227;o deste dom&#237;nio (OR: 0,21; IC<sub>95%</sub>: 0,06-0,71; p = 0,01). ICP pr&#233;via e sobrepeso/obesidade contribu&#237;ram para o preju&#237;zo dessa vari&#225;vel (OR: 3,3; IC<sub>95%</sub>: 1,08-10,07; p = 0,035 e OR: 4,3; IC<sub>95%</sub>: 1,19-15,85; p = 0,02, respectivamente).</p>
    <p>Doze meses ap&#243;s o procedimento, foram obtidas as informa&#231;&#245;es completas referentes a 74 indiv&#237;duos. Quatro casos foram exclu&#237;dos pela falta de dados nos prontu&#225;rios m&#233;dicos e pela indisponibilidade do contato telef&#244;nico. Nesse per&#237;odo, 13 dos 74 <italic>stents</italic> apresentaram reestenoses identificadas em nova coronariografia. Foram realizadas novas interven&#231;&#245;es em 11 vasos.</p>
    <p>Dezessete pacientes apresentaram, pelo menos, um dos desfechos cl&#237;nicos desfavor&#225;veis. Cinco pacientes foram a &#243;bito, 7 necessitaram de interna&#231;&#227;o devido &#224; IC, 10 apresentaram IAM n&#227;o fatal.</p>
    <p>O sexo feminino (OR: 7,19; IC<sub>95%</sub>: 1,55-33,36; p = 0,012), evento cardiovascular pr&#233;vio (OR: 3,97; IC<sub>95%</sub>: 1,01-15,66; p = 0,049) e insucesso na ICP (OR: 10,60; IC<sub>95%</sub>: 1,83-61,46; p = 0,008) foram associados com risco aumentado de desfecho combinado.</p>
    <p>
      <bold>Discuss&#227;o</bold>
    </p>
    <p>O presente estudo teve como objetivo avaliar os fatores associados com preju&#237;zo da qualidade de vida em pacientes com doen&#231;a arterial coron&#225;ria grave e est&#225;vel. Tamb&#233;m foram analisadas as associa&#231;&#245;es entre atributos cl&#237;nicos e desfechos desfavor&#225;veis ap&#243;s a angioplastia.</p>
    <p>A popula&#231;&#227;o inclu&#237;da era caracteristicamente idosa, com sobrepeso e sem controle ideal de fatores de risco cardiovascular modific&#225;veis. Esse achado &#233; relevante, tendo em vista que tais pacientes j&#225; apresentavam les&#227;o de &#243;rg&#227;o-alvo. Identificou-se falta de controle ideal da press&#227;o arterial em 51,0% dos pacientes, da glicemia em 44,0% e do perfil lip&#237;dico em 68,0%. Al&#233;m disso, foram identificados 36 casos com sobrepeso e 14 casos com obesidade.</p>
    <p>Essa dificuldade para controlar todos os fatores de risco cardiovascular &#233; frequentemente descrita na literatura<sup>19</sup>. Em um levantamento feito pelo Minist&#233;rio da Sa&#250;de e Organiza&#231;&#227;o Pan-Americana da Sa&#250;de, intitulado "Avalia&#231;&#227;o do Plano de Reorganiza&#231;&#227;o da Aten&#231;&#227;o &#224; Hipertens&#227;o Arterial e ao <italic>Diabetes Mellitus</italic> no Brasil", 36,0% dos indiv&#237;duos rastreados apresentavam n&#237;veis de press&#227;o arterial maiores ou iguais a 140 x 90 mmHg; 16,4% dos indiv&#237;duos apresentaram glicemia alterada. O estado nutricional, avaliado por meio do &#237;ndice de massa corporal, mostrou que 30,8% apresentavam sobrepeso (IMC &gt; 25 e &lt; 30 kg/m<sup>2</sup>) e que 19,4% eram obesos (IMC &gt; 30,0 kg/m<sup>2</sup>)<sup>20</sup>.</p>
    <p>Na casu&#237;stica avaliada neste estudo, os EQV mostraram-se diminu&#237;dos em todos os quesitos, levando-se em conta os valores obtidos em indiv&#237;duos normais e descritos na literatura<sup>21-23</sup>. Os valores observados s&#227;o semelhantes aos observados por outros autores nacionais que avaliaram pacientes com DAC<sup>1</sup>. Especialmente, o quesito Aspectos F&#237;sicos esteve bastante prejudicado, com 50,0% dos pacientes apresentando escore abaixo de 50. Nossos dados n&#227;o permitem concluir sobre todas as causas dessa altera&#231;&#227;o, mas estariam em acordo com o estudo de Spertus e cols.<sup>4</sup>, que descreveram preju&#237;zo do estado funcional relacionado &#224; doen&#231;a em pacientes com CAD e sintomas depressivos.</p>
    <p>As mulheres apresentaram menor capacidade funcional, al&#233;m de referirem mais dor e terem a sa&#250;de mental prejudicada. H&#225; relatos na literatura de que, durante a experi&#234;ncia da doen&#231;a, as mulheres t&#234;m maior comprometimento da sa&#250;de mental<sup>24-26</sup>. Pode ser que essa caracter&#237;stica esteja associada &#224; maior capacidade de verbaliza&#231;&#227;o das mulheres, durante a avalia&#231;&#227;o<sup>27</sup>. Tamb&#233;m pode estar associada a fatores socioculturais que implicam em maior jornada de trabalho, preconceitos e outros fatores.</p>
    <p>Foi surpreendente a observa&#231;&#227;o de que indiv&#237;duos com idade maior ou igual a 60 anos referiram melhor Capacidade Funcional. Uma poss&#237;vel explica&#231;&#227;o para esse resultado pode ser o maior impacto que a doen&#231;a fisicamente limitante causa nos indiv&#237;duos mais jovens. Isto &#233;, pacientes previamente mais ativos, quando comparados com pacientes j&#225; aposentados e menos ativos, podem experimentar maior dificuldade com a imposi&#231;&#227;o de repouso ou incapacidade para o trabalho.</p>
    <p>As demais vari&#225;veis associadas com preju&#237;zo dos EQV, de fato, refletem a presen&#231;a de comorbidades ou doen&#231;a coronariana mais antiga ou mais grave. A presen&#231;a de DM, hipertens&#227;o arterial n&#227;o controlada, sobrepeso/obesidade e eventos cardiovasculares repetidos s&#227;o condi&#231;&#245;es que contribuem para o agravamento de sa&#250;de e afetam as atividades cotidianas dos indiv&#237;duos<sup>28</sup>. Assim, embora os resultados obtidos fossem esperados, chamou aten&#231;&#227;o o pequeno n&#250;mero de refer&#234;ncias na literatura que abordassem tal aspecto no caso espec&#237;fico de pacientes com doen&#231;a ateroscler&#243;tica coronariana. Miralda e cols.<sup>26</sup> avaliaram pacientes ap&#243;s cirurgia de revasculariza&#231;&#227;o mioc&#225;rdica e encontraram que a presen&#231;a de m&#250;ltiplos fatores de risco e o sexo feminino estavam relacionados a preju&#237;zo da qualidade de vida. Em publica&#231;&#227;o posterior, esses autores identificaram qualidade de vida preservada nos pacientes ap&#243;s a angioplastia<sup>27</sup>.</p>
    <p>Diferentemente, nosso estudo n&#227;o avaliou a associa&#231;&#227;o dos escores de qualidade de vida com desfechos ap&#243;s a angioplastia, pois teve como objetivo avaliar o preju&#237;zo da qualidade de vida em pacientes com DAC antes do procedimento.</p>
    <p>Um aspecto que merece discuss&#227;o &#233; a poss&#237;vel implica&#231;&#227;o do preju&#237;zo da qualidade de vida e sintomas depressivos no progn&#243;stico desses pacientes. Tr&#234;s mecanismos fisiopatol&#243;gicos podem estar envolvidos<sup>29</sup>. Primeiramente, a depress&#227;o pode ser acompanhada de hipercortisolemia, componente pr&#243;-ateroscler&#243;tico j&#225; bem conhecido<sup>30</sup>. Em segundo lugar, indiv&#237;duos depressivos podem apresentar maior agrega&#231;&#227;o plaquet&#225;ria e libera&#231;&#227;o de componente pr&#243;-inflamat&#243;rios<sup>31</sup>. Finalmente, podem tamb&#233;m apresentar menor variabilidade da frequ&#234;ncia card&#237;aca e t&#244;nus vagal diminu&#237;do, favorecendo a maior incid&#234;ncia de eventos arritmog&#234;nicos<sup>32,33</sup>. H&#225; aumento da press&#227;o arterial, vasoconstri&#231;&#227;o e disfun&#231;&#227;o endotelial, acelerando fen&#244;menos ateroscler&#243;ticos<sup>34,35</sup>.</p>
    <p>Foi relevante a observa&#231;&#227;o de maior risco de desfecho combinado em mulheres, pacientes com evento cardiovascular pr&#233;vio ou insucesso na ICP, mesmo numa casu&#237;stica relativamente pequena como esta apresentada. Evento pr&#233;vio e insucesso no procedimento s&#227;o fatores de f&#225;cil entendimento, visto que refletem a doen&#231;a mais grave. Por outro lado, a quest&#227;o de maior risco em mulheres deve ser analisada melhor, j&#225; que &#233; menos compreendida.</p>
    <p>H&#225; diversos fatores que podem explicar a associa&#231;&#227;o do sexo feminino ao maior risco de desfecho cardiovascular desfavor&#225;vel. Em geral, as mulheres com DAC s&#227;o mais idosas e apresentam maior n&#250;mero de comorbidades<sup>36</sup>. V&#225;rios mecanismos t&#234;m sido implicados, como a diminui&#231;&#227;o de secre&#231;&#227;o de estr&#243;geno na p&#243;s-menopausa. O estr&#243;geno &#233; o fator respons&#225;vel pelo retardo da atividade ateroscler&#243;tica durante a idade f&#233;rtil, com aumento dos n&#237;veis do HDL e prote&#231;&#227;o cardiovascular.</p>
    <p>Um aspecto interessante &#233; que as mulheres tamb&#233;m apresentaram maior risco de preju&#237;zo de qualidade de vida. Essa observa&#231;&#227;o poderia sugerir que os dois fen&#244;menos est&#227;o relacionados. Isto &#233;, o maior risco de eventos em mulheres poderia estar associado, em parte, ao fato apresentarem mais sintomas depressivos e com ajustamento psicossocial mais pobre frente a um evento cardiovascular<sup>11</sup>. No entanto, a associa&#231;&#227;o entre preju&#237;zo da qualidade de vida e desfechos desfavor&#225;veis n&#227;o foi avaliada no presente estudo. Isto se deu porque a ICP foi realizada ap&#243;s a defini&#231;&#227;o dos escores, o que poderia se constituir em vi&#233;s de interpreta&#231;&#227;o. Apesar disso, vale a pena ressaltar as evid&#234;ncias de que mulheres com menor conv&#237;vio e integra&#231;&#227;o social e sintomas depressivos t&#234;m maior o risco de desfechos cl&#237;nicos desfavor&#225;veis na presen&#231;a de DAC<sup>37,38</sup>. Al&#233;m disso, m&#225; qualidade de vida e estresse emocional causariam disfun&#231;&#227;o ovariana, menor secre&#231;&#227;o estrog&#234;nica, ativa&#231;&#227;o neuroend&#243;crina e hipercortisolemia, acelerando o processo ateroscler&#243;tico<sup>39,40</sup> e fechando o ciclo vicioso.</p>
    <p>
      <bold>Conclus&#227;o</bold>
    </p>
    <p>A qualidade de vida encontra-se prejudicada em pacientes com DAC grave e est&#225;vel. Esse preju&#237;zo &#233; acentuado em mulheres e pacientes com outras comorbidades, como DM, sobrepeso, obesidade, hipertens&#227;o n&#227;o controlada e evento cardiovascular ou ICP pr&#233;vios. Doze meses ap&#243;s a ICP, houve maior risco de desfechos desfavor&#225;veis em mulheres e em pacientes com evento cardiovascular pr&#233;vio ou com insucesso no procedimento.</p>
    <p>
      <bold>Potencial Conflito de Interesses</bold>
    </p>
    <p>Declaro n&#227;o haver conflito de interesses pertinentes.</p>
    <p>
      <bold>Fontes de Financiamento</bold>
    </p>
    <p>O presente estudo n&#227;o teve fontes de financiamento externas.</p>
    <p>
      <bold>Vincula&#231;&#227;o Acad&#234;mica</bold>
    </p>
    <p>N&#227;o h&#225; vincula&#231;&#227;o deste estudo a programas de p&#243;s-gradua&#231;&#227;o.</p>
    <p>
      <fn id="back" fn-type="corresp">
        <p>Correspond&#234;ncia:</p>
        <p> Meliza Goi Roscani </p>
        <p> Departamento de Cl&#237;nica M&#233;dica da Faculdade de Medicina de Botucatu - UNESP </p>
        <p> Distrito de Rubi&#227;o J&#250;nior, s/n&#186; - 18618- 970 - Botucatu, SP - Brasil </p>
        <p> E-mail: </p>
        <p>
          <email xlink:href="meliza10@hotmail.com">meliza10@hotmail.com</email>
        </p>
      </fn>
    </p>
    <p>Artigo recebido em 22/11/09; revisado recebido em 17/06/10; aceito em 15/07/10.</p>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation>1. Takiuti ME,    Hueb WH, Hiscock SB, Nogueira CRSR, Girardi P, Fernandes F, et al. Qualidade    de vida ap&#243;s revasculariza&#231;&#227;o cir&#250;rgica do mioc&#225;rdio,    angioplastia ou tratamento cl&#237;nico. Arq Bras Cardiol. 2007; 88 (5): 537-44.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Qualidade de vida ap&#243;s revasculariza&#231;&#227;o cir&#250;rgica do mioc&#225;rdio, angioplastia ou tratamento cl&#237;nico</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>537</fpage>
          <lpage>44</lpage>
          <issue>5</issue>
          <volume>88</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Takiuti</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Hueb</surname>
              <given-names>WH</given-names>
            </name>
            <name>
              <surname>Hiscock</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Nogueira</surname>
              <given-names>CRSR</given-names>
            </name>
            <name>
              <surname>Girardi</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Fernandes</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B2">
        <mixed-citation>2. Ruo B, Rumsfeld    JS, Hlatky MA, Liu H, Browner WS, Whooley MA. Depressive symptoms and health-related    quality of life: the heart and soul study. JAMA. 2003; 290 (2): 215-21.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Depressive symptoms and health-related quality of life: the heart and soul study</article-title>
          <source>JAMA</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>215</fpage>
          <lpage>21</lpage>
          <issue>2</issue>
          <volume>290</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ruo</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Rumsfeld</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Hlatky</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Browner</surname>
              <given-names>WS</given-names>
            </name>
            <name>
              <surname>Whooley</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B3">
        <mixed-citation>3. Lett HS, Blumenthal    JA, Babyak MA, Sherwood A, Strauman T, Robins C, et al. Depression as a risk    factor for coronary artery disease: evidence, mechanisms and treatment. Psychosom    Med. 2004; 66 (3): 305-15.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Depression as a risk factor for coronary artery disease: evidence, mechanisms and treatment</article-title>
          <source>Psychosom Med</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>305</fpage>
          <lpage>15</lpage>
          <issue>3</issue>
          <volume>66</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Lett</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Blumenthal</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Babyak</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Sherwood</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Strauman</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Robins</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B4">
        <mixed-citation>4. Spertus JA,    McDonell M, Woodman CL, Fihn SD. Association between depression and worse disease-specific    functional status in outpatients with coronary artery disease. Am Heart J. 2000;    140 (1): 105-10.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Association between depression and worse disease-specific functional status in outpatients with coronary artery disease</article-title>
          <source>Am Heart J</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>105</fpage>
          <lpage>10</lpage>
          <issue>1</issue>
          <volume>140</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Spertus</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>McDonell</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Woodman</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Fihn</surname>
              <given-names>SD</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B5">
        <mixed-citation>5. Legrand VMG,    Serruys PW, Unger F, van Hout BA, Vrolix MCM, Fransen GMP, et al, (on behalf    of the Arterial Revascularization Therapy Study (ARTS)). Three-year outcome    after coronary stenting versus bypass surgery for the treatment of multivessel    disease. Circulation. 2004; 109 (9): 1114-20.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Three-year outcome after coronary stenting versus bypass surgery for the treatment of multivessel disease</article-title>
          <source>Circulation</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>1114</fpage>
          <lpage>20</lpage>
          <issue>9</issue>
          <volume>109</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Legrand</surname>
              <given-names>VMG</given-names>
            </name>
            <name>
              <surname>Serruys</surname>
              <given-names>PW</given-names>
            </name>
            <name>
              <surname>Unger</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>van Hout</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Vrolix</surname>
              <given-names>MCM</given-names>
            </name>
            <name>
              <surname>Fransen</surname>
              <given-names>GMP</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B6">
        <mixed-citation>6. Spertus J, Winder    JA, Dewhurst TA, Deyo RA, Prodzinski J, McDonell, et al. Development and evaluation    of the Seattle Angina Questionnaire: a new functional status measure for coronary    artery disease. J Am Coll Cardiol. 1995; 25 (2): 333-41.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>1995</year>
          </date>
          <fpage>333</fpage>
          <lpage>41</lpage>
          <issue>2</issue>
          <volume>25</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Spertus</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Winder</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Dewhurst</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Deyo</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Prodzinski</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>McDonell</surname>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B7">
        <mixed-citation>7. Lukkarinen HRN,    Hentinen M. Assessment of quality of life with the Nottingham Health Profile    among patients with coronary heart disease. J Adv Nursing. 1997; 26 (1): 73-84.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Assessment of quality of life with the Nottingham Health Profile among patients with coronary heart disease</article-title>
          <source>J Adv Nursing</source>
          <date>
            <year>1997</year>
          </date>
          <fpage>73</fpage>
          <lpage>84</lpage>
          <issue>1</issue>
          <volume>26</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Lukkarinen</surname>
              <given-names>HRN</given-names>
            </name>
            <name>
              <surname>Hentinen</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B8">
        <mixed-citation>8. Melville MR,    Lari MA, Brown N, Young T, Gray D. Quality of life assessment using the short    form 12 questionnaire is as reliable and sensitive as the short-form 36 in distinguishing    symptom severity in miocardial infarction survivors. Heart. 2003; 89 (12): 1445-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Quality of life assessment using the short form 12 questionnaire is as reliable and sensitive as the short-form 36 in distinguishing symptom severity in miocardial infarction survivors</article-title>
          <source>Heart</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>1445</fpage>
          <lpage>6</lpage>
          <issue>12</issue>
          <volume>89</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Melville</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Lari</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Gray</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B9">
        <mixed-citation>9. Reis MG, Glashan    RQ. Adultos hipertensos hospitalizados: percep&#231;&#227;o de gravidade    da doen&#231;a e de qualidade de vida. Rev Latino-Amer Enf. 2001; 9 (3): 51-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Adultos hipertensos hospitalizados: percep&#231;&#227;o de gravidade da doen&#231;a e de qualidade de vida</article-title>
          <source>Rev Latino-Amer Enf</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>51</fpage>
          <lpage>7</lpage>
          <issue>3</issue>
          <volume>9</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Reis</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Glashan</surname>
              <given-names>RQ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B10">
        <mixed-citation>10. Cassar K, Bachoo    P, Brittenden J. The effect of peripheral percutaneous transluminal angioplasty    on quality of life in patients with intermittent claudication. Eur J Vasc Endovasc    Surg. 2003; 26 (2): 130-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The effect of peripheral percutaneous transluminal angioplasty on quality of life in patients with intermittent claudication</article-title>
          <source>Eur J Vasc Endovasc Surg</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>130</fpage>
          <lpage>6</lpage>
          <issue>2</issue>
          <volume>26</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Cassar</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Bachoo</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Brittenden</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B11">
        <mixed-citation>11. Ciconelli RM.    Valida&#231;&#227;o do question&#225;rio gen&#233;rico de avalia&#231;&#227;o    de qualidade de vida : "Medical outcomes study 36-item Short-form health survey    (SF-36)". [disserta&#231;&#227;o]. S&#227;o Paulo: Escola Paulista    de Medicina: Universidade Federal de S&#227;o Paulo; 1999.</mixed-citation>
        <element-citation publication-type="book">
          <source>Valida&#231;&#227;o do question&#225;rio gen&#233;rico de avalia&#231;&#227;o de qualidade de vida: "Medical outcomes study 36-item Short-form health survey (SF-36)"</source>
          <date>
            <year>1999</year>
          </date>
          <person-group person-group-type="author">
            <name>
              <surname>Ciconelli</surname>
              <given-names>RM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B12">
        <mixed-citation>12. Norris CM,    Ghali WA, Galbraith PD, Graham MM, Jensen LA, Knudtson ML, et al. Women with    coronary artery disease report worse health-related quality of life outcomes    compared to men. Health Qual Life Outcomes. 2004; 2: 21-32.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Women with coronary artery disease report worse health-related quality of life outcomes compared to men</article-title>
          <source>Health Qual Life Outcomes</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>21</fpage>
          <lpage>32</lpage>
          <volume>2</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Norris</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Ghali</surname>
              <given-names>WA</given-names>
            </name>
            <name>
              <surname>Galbraith</surname>
              <given-names>PD</given-names>
            </name>
            <name>
              <surname>Graham</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Jensen</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Knudtson</surname>
              <given-names>ML</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B13">
        <mixed-citation>13. Horsten M,    Mittleman MA, Wamala SP, Schenck-Gustafsson K, Orth-Gom&#233;r K. Depressive    symptoms and lack of social integration in relation to prognosis of CHD in middle-aged    women. Eur Heart J. 2000; 21 (13): 1072-80.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Depressive symptoms and lack of social integration in relation to prognosis of CHD in middle-aged women</article-title>
          <source>Eur Heart J</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>1072</fpage>
          <lpage>80</lpage>
          <issue>13</issue>
          <volume>21</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Horsten</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mittleman</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Wamala</surname>
              <given-names>SP</given-names>
            </name>
            <name>
              <surname>Schenck-Gustafsson</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Orth-Gom&#233;r</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B14">
        <mixed-citation>14. Favarato MECS,    Favarato D, Hueb WA, Aldrighi JM. Qualidade de vida em portadores de doen&#231;a    arterial coron&#225;ria: compara&#231;&#227;o entre g&#234;neros. Rev    Assoc Med Bras. 2006; 52 (4): 236-41.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Qualidade de vida em portadores de doen&#231;a arterial coron&#225;ria: compara&#231;&#227;o entre g&#234;neros</article-title>
          <source>Rev Assoc Med Bras</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>236</fpage>
          <lpage>41</lpage>
          <issue>4</issue>
          <volume>52</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Favarato</surname>
              <given-names>MECS</given-names>
            </name>
            <name>
              <surname>Favarato</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Hueb</surname>
              <given-names>WA</given-names>
            </name>
            <name>
              <surname>Aldrighi</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B15">
        <mixed-citation>15. Pocock SJ,    Henderson RA, Clayton T, Lyman GH, Chamberlain DA. Quality of life after coronary    angioplasty or continued medical tratment for angina: three-year follow-up in    the RITA-2 trial. J Am Coll Cardiol. 2000; 35 (14): 907-14.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Quality of life after coronary angioplasty or continued medical tratment for angina: three-year follow-up in the RITA-2 trial</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>907</fpage>
          <lpage>14</lpage>
          <issue>14</issue>
          <volume>35</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Pocock</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Henderson</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Clayton</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Lyman</surname>
              <given-names>GH</given-names>
            </name>
            <name>
              <surname>Chamberlain</surname>
              <given-names>DA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B16">
        <mixed-citation>16. Mion Jr D,    Machado CA, Gomes MAM, Nobre F, Kohlmann Jr O, Amodeo C, et al / Sociedade Brasileira    de Cardiologia. IV Diretrizes brasileiras de hipertens&#227;o arterial. Arq    Bras Cardiol. 2004; 82 (supl. 4): 1-14.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>IV Diretrizes brasileiras de hipertens&#227;o arterial</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>1</fpage>
          <lpage>14</lpage>
          <volume>82</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Mion Jr</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Machado</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Gomes</surname>
              <given-names>MAM</given-names>
            </name>
            <name>
              <surname>Nobre</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Kohlmann Jr</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Amodeo</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B17">
        <mixed-citation>17. American Diabetes    Association. Standards of medical care in diabetes. Diabetes Care. 2005; 28    (Suppl.1): 4-36.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Standards of medical care in diabetes</article-title>
          <source>Diabetes Care</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>4</fpage>
          <lpage>36</lpage>
          <volume>28</volume>
        </element-citation>
      </ref>
      <ref id="B18">
        <mixed-citation>18. Sposito AC,    Caramelli B, Fonseca FAH, Bertolami MC, Afiune Neto A, Souza AD, et al / Sociedade    Brasileira de Aterosclerose / Sociedade Brasileira de Cardiologia. IV Diretriz    brasileira sobre dislipidemias e preven&#231;&#227;o da aterosclerose. Arq    Bras Cardiol. 2007; 88 (supl 1): 2-19.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>IV Diretriz brasileira sobre dislipidemias e preven&#231;&#227;o da aterosclerose</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>2</fpage>
          <lpage>19</lpage>
          <volume>88</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Sposito</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Caramelli</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Fonseca</surname>
              <given-names>FAH</given-names>
            </name>
            <name>
              <surname>Bertolami</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Afiune Neto</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Souza</surname>
              <given-names>AD</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B19">
        <mixed-citation>19. Castro M, Caiuby    AVS, Draibe SA, Canziani MEF. Qualidade de vida de pacientes com insufici&#234;ncia    renal cr&#244;nica em hemodi&#225;lise avaliada atrav&#233;s do instrumento    gen&#233;rico SF-36. Rev Assoc Med Bras. 2003; 49 (3): 245-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Qualidade de vida de pacientes com insufici&#234;ncia renal cr&#244;nica em hemodi&#225;lise avaliada atrav&#233;s do instrumento gen&#233;rico SF-36</article-title>
          <source>Rev Assoc Med Bras</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>245</fpage>
          <lpage>9</lpage>
          <issue>3</issue>
          <volume>49</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Castro</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Caiuby</surname>
              <given-names>AVS</given-names>
            </name>
            <name>
              <surname>Draibe</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Canziani</surname>
              <given-names>MEF</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B20">
        <mixed-citation>20. Lessa I. No    compliance to hypertension treatment - social and economic impact. Rev Bras    Hipertens. 2006; 13 (1): 39-46.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>No compliance to hypertension treatment - social and economic impact</article-title>
          <source>Rev Bras Hipertens</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>39</fpage>
          <lpage>46</lpage>
          <issue>1</issue>
          <volume>13</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Lessa</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B21">
        <label>21</label>
        <mixed-citation>21. Minist&#233;rio da Sa&#250;de/ Organiza&#231;&#227;o Pan-Americana da Sa&#250;de. Avalia&#231;&#227;o do plano de reorganiza&#231;&#227;o da aten&#231;&#227;o &#224; hipertens&#227;o arterial e ao Diabetes Mellitus no Brasil. [Acesso em 2006 jun 20]. Dispon&#237;vel em <ext-link ext-link-type="uri" xlink:href="http://departamentos.cardiol.br/dha/revista/aval_plano_reorg/impacto.pdf">http://departamentos.cardiol.br/dha/revista/aval_plano_reorg/impacto.pdf</ext-link></mixed-citation>
        <element-citation publication-type="book">
          <source>Avalia&#231;&#227;o do plano de reorganiza&#231;&#227;o da aten&#231;&#227;o &#224; hipertens&#227;o arterial e ao Diabetes Mellitus no Brasil</source>
        </element-citation>
      </ref>
      <ref id="B22">
        <mixed-citation>22. Pagano T, Matsutani    LA, Ferreira EAG, Marques AP, Pereira CAB. Assessment of anxiety and quality    of life in fibromyalgia patients. S&#227;o Paulo Med J. 2004;122 (6): 252-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Assessment of anxiety and quality of life in fibromyalgia patients</article-title>
          <source>S&#227;o Paulo Med J</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>252</fpage>
          <lpage>8</lpage>
          <issue>6</issue>
          <volume>122</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Pagano</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Matsutani</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Ferreira</surname>
              <given-names>EAG</given-names>
            </name>
            <name>
              <surname>Marques</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Pereira</surname>
              <given-names>CAB</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B23">
        <mixed-citation>23. Devereux K,    Robertson D, Briffa NK. Effects of a water-based program on women 65 years and    over: a randomised controlled trial. Australian J Physiother. 2005; 51 (2):    102-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Effects of a water-based program on women 65 years and over: a randomised controlled trial</article-title>
          <source>Australian J Physiother</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>102</fpage>
          <lpage>8</lpage>
          <issue>2</issue>
          <volume>51</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Devereux</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Robertson</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Briffa</surname>
              <given-names>NK</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B24">
        <mixed-citation>24. Le Pen C, Levy    E, Loos F, Banzet MN, Basdevant A. "Specific" scale compared with "generic"    scale: a double measurement of the quality of life in a French community sample    of obese subjects. J Epidemiol Community Health. 1998; 52 (7): 445-50.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>"Specific" scale compared with "generic" scale: a double measurement of the quality of life in a French community sample of obese subjects</article-title>
          <source>J Epidemiol Community Health</source>
          <date>
            <year>1998</year>
          </date>
          <fpage>445</fpage>
          <lpage>50</lpage>
          <issue>7</issue>
          <volume>52</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Le Pen</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Levy</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Loos</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Banzet</surname>
              <given-names>MN</given-names>
            </name>
            <name>
              <surname>Basdevant</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B25">
        <mixed-citation>25. Pischke CR,    Weidner G, Elliot-Eller M, Scherwitz L, Merrit-Worden TA, Marlin R, et al. Comparison    of coronary risk factors and quality of life in coronary artery disease patients    with versus without diabetes mellitus. Am J Cardiol. 2006; 97 (9): 1267-73.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Comparison of coronary risk factors and quality of life in coronary artery disease patients with versus without diabetes mellitus</article-title>
          <source>Am J Cardiol</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>1267</fpage>
          <lpage>73</lpage>
          <issue>9</issue>
          <volume>97</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Pischke</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Weidner</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Elliot-Eller</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Scherwitz</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Merrit-Worden</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Marlin</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B26">
        <mixed-citation>26. Permanyer Miralda    C, Brotons Cuixart C, Ribera Sol&#233; A, Moral Pel&#225;ez I, Cascant Castell&#243;    P, Alonso J, et al. Outcomes of coronary artery surgery: determinants of quality    of life related to postoperative health. Rev Esp Cardiol. 2001; 54 (5): 607-16.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Outcomes of coronary artery surgery: determinants of quality of life related to postoperative health</article-title>
          <source>Rev Esp Cardiol</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>607</fpage>
          <lpage>16</lpage>
          <issue>5</issue>
          <volume>54</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Permanyer Miralda</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Brotons Cuixart</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ribera Sol&#233;</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Moral Pel&#225;ez</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Cascant Castell&#243;</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Alonso</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B27">
        <mixed-citation>27. Permanyer Miralda    C, Brotons Cuixart C, Ribera Sol&#233; A, Cascant Castell&#243; P, Moral    Pel&#225;ez I, Alonso J, et al. Clinical outcome and health related quality    of life in patients undergoing coronary angioplasty with balloon or stent. A    prospective multicenter study. Rev Esp Cardiol. 2001; 54 (5): 597-606.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Clinical outcome and health related quality of life in patients undergoing coronary angioplasty with balloon or stent: A prospective multicenter study</article-title>
          <source>Rev Esp Cardiol</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>597</fpage>
          <lpage>606</lpage>
          <issue>5</issue>
          <volume>54</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Permanyer Miralda</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Brotons Cuixart</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ribera Sol&#233;</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Cascant Castell&#243;</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Moral Pel&#225;ez</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Alonso</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B28">
        <mixed-citation>28. Alvarez SE,    Friedman EJ, Beckman E, Blackwell M, Chinchila NS, Lebon N, et al. Encontrando    os feminismos latino-americanos e caribenhos. Rev Estud Fem. 2003; 11: 541-75.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Encontrando os feminismos latino-americanos e caribenhos</article-title>
          <source>Rev Estud Fem</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>541</fpage>
          <lpage>75</lpage>
          <volume>11</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Alvarez</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Friedman</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Beckman</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Blackwell</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Chinchila</surname>
              <given-names>NS</given-names>
            </name>
            <name>
              <surname>Lebon</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B29">
        <mixed-citation>29. Jiang Y, Hesser    JE. Associations between health-related quality of life and demographics and    health risks: results from Rhode Island's 2002 behavioral risk factor survey.    Health Qual Life Outcomes. 2006; 4: 14.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Associations between health-related quality of life and demographics and health risks: results from Rhode Island's 2002 behavioral risk factor survey</article-title>
          <source>Health Qual Life Outcomes</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>14</fpage>
          <volume>4</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Jiang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Hesser</surname>
              <given-names>JE</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B30">
        <mixed-citation>30. Rozanski A,    Blumenthal J&#193;, Kaplan J. Impact of psychological factors on the pathogenesis    of cardiovascular disease. Circulation. 1999; 99 (16): 2192-217.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Impact of psychological factors on the pathogenesis of cardiovascular disease</article-title>
          <source>Circulation</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>2192</fpage>
          <lpage>217</lpage>
          <issue>16</issue>
          <volume>99</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Rozanski</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Blumenthal</surname>
              <given-names>J&#193;</given-names>
            </name>
            <name>
              <surname>Kaplan</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B31">
        <mixed-citation>31. Caroll BJ,    Curtis GC, Davies BM, Mendels J, Sugarman AA. Urinary free cortisol excretion    in depression. Psychol Med. 1976; 6 (1): 43-50.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Urinary free cortisol excretion in depression</article-title>
          <source>Psychol Med</source>
          <date>
            <year>1976</year>
          </date>
          <fpage>43</fpage>
          <lpage>50</lpage>
          <issue>1</issue>
          <volume>6</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Caroll</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Curtis</surname>
              <given-names>GC</given-names>
            </name>
            <name>
              <surname>Davies</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Mendels</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Sugarman</surname>
              <given-names>AA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B32">
        <mixed-citation>32. Musselman DL,    Tomer A, Manatunga AK, Knight BT, Porter MR, Kasey S, et al. Exaggerated platelet    reactivity in major depression. Am J Psychiatry. 1996; 153 (10): 1313-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Exaggerated platelet reactivity in major depression</article-title>
          <source>Am J Psychiatry</source>
          <date>
            <year>1996</year>
          </date>
          <fpage>1313</fpage>
          <lpage>7</lpage>
          <issue>10</issue>
          <volume>153</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Musselman</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Tomer</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Manatunga</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Knight</surname>
              <given-names>BT</given-names>
            </name>
            <name>
              <surname>Porter</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Kasey</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B33">
        <mixed-citation>33. Carney RM,    Saunders RD, Freedland KE, Stein P, Rich MW, Jaffe AS. Association of depression    with reduced heart rate variability in coronary artery disease. Am J Cardiol.    1995; 76 (8): 562-4.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Association of depression with reduced heart rate variability in coronary artery disease</article-title>
          <source>Am J Cardiol</source>
          <date>
            <year>1995</year>
          </date>
          <fpage>562</fpage>
          <lpage>4</lpage>
          <issue>8</issue>
          <volume>76</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Carney</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Saunders</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Freedland</surname>
              <given-names>KE</given-names>
            </name>
            <name>
              <surname>Stein</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Rich</surname>
              <given-names>MW</given-names>
            </name>
            <name>
              <surname>Jaffe</surname>
              <given-names>AS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B34">
        <mixed-citation>34. Watkins LL,    Grossman P. Association of depressive symptoms with reduced baroreflex cardiac    control in coronary artery disease. Am Heart J. 1999; 37 (3): 453-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Association of depressive symptoms with reduced baroreflex cardiac control in coronary artery disease</article-title>
          <source>Am Heart J</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>453</fpage>
          <lpage>7</lpage>
          <issue>3</issue>
          <volume>37</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Watkins</surname>
              <given-names>LL</given-names>
            </name>
            <name>
              <surname>Grossman</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B35">
        <mixed-citation>35. Kawachi I,    Sparrow D, Vokonas PS, Weiss ST. Decreased heart rate variability in men with    phobic anxiety (data from the Normative Aging Study). Am J Cardiol. 1995; 75    (14): 882-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Decreased heart rate variability in men with phobic anxiety (data from the Normative Aging Study)</article-title>
          <source>Am J Cardiol</source>
          <date>
            <year>1995</year>
          </date>
          <fpage>882</fpage>
          <lpage>5</lpage>
          <issue>14</issue>
          <volume>75</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Kawachi</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Sparrow</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Vokonas</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Weiss</surname>
              <given-names>ST</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B36">
        <mixed-citation>36. Isles CG, Hole    DJ, Hawthorne VM, Lever AF. Relation between coronary risk and coronary mortality    in women of the Renfrew and Paisley survey: comparison with men. Lancet. 1992;    339 (8795): 702-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Relation between coronary risk and coronary mortality in women of the Renfrew and Paisley survey: comparison with men</article-title>
          <source>Lancet</source>
          <date>
            <year>1992</year>
          </date>
          <fpage>702</fpage>
          <lpage>6</lpage>
          <issue>8795</issue>
          <volume>339</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Isles</surname>
              <given-names>CG</given-names>
            </name>
            <name>
              <surname>Hole</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Hawthorne</surname>
              <given-names>VM</given-names>
            </name>
            <name>
              <surname>Lever</surname>
              <given-names>AF</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B37">
        <mixed-citation>37. Lown B, Verrier    RL, Corbalan R. Psychologic stress and threshold for repetitive ventricular    response. Science. 1973; 182 (114): 834-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Psychologic stress and threshold for repetitive ventricular response</article-title>
          <source>Science</source>
          <date>
            <year>1973</year>
          </date>
          <fpage>834</fpage>
          <lpage>6</lpage>
          <issue>114</issue>
          <volume>182</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Lown</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Verrier</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Corbalan</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B38">
        <mixed-citation>38. Kaplan JR,    Adams MR, Clarkson TB, Manuck SB, Shively CA, Williams JK. Psychosocial factors,    sex differences, and atherosclerosis: lessons from animal models. Psychosom    Med. 1996; 58 (6): 598-611.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Psychosocial factors, sex differences, and atherosclerosis: lessons from animal models</article-title>
          <source>Psychosom Med</source>
          <date>
            <year>1996</year>
          </date>
          <fpage>598</fpage>
          <lpage>611</lpage>
          <issue>6</issue>
          <volume>58</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Kaplan</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Adams</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Clarkson</surname>
              <given-names>TB</given-names>
            </name>
            <name>
              <surname>Manuck</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Shively</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>JK</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B39">
        <mixed-citation>39. Frasure-Smith    N, Lesp&#233;rance F, Juneau M, Talajic M, Bourassa MG. Gender, depression,    and one-year prognosis after myocardial infarction. . Psychosom Med. 1999; 61    (1): 26-37.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Gender, depression, and one-year prognosis after myocardial infarction</article-title>
          <source>Psychosom Med</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>26</fpage>
          <lpage>37</lpage>
          <issue>1</issue>
          <volume>61</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Frasure-Smith</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Lesp&#233;rance</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Juneau</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Talajic</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bourassa</surname>
              <given-names>MG</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B40">
        <mixed-citation>40. Ballinger S.    Stress as a factor in lowered estrogen levels in the early postmenopause. Ann    NY Acad Sci. 1990; 592: 95-113.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Stress as a factor in lowered estrogen levels in the early postmenopause</article-title>
          <source>Ann NY Acad Sci</source>
          <date>
            <year>1990</year>
          </date>
          <fpage>95</fpage>
          <lpage>113</lpage>
          <volume>592</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ballinger</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Quality of life in patients with severe and stable coronary atherosclerotic disease</article-title>
      </title-group>
      <abstract xml:lang="en">
        <p>BACKGROUND: There are few data on the factors decreasing quality of life (QoL) in patients with coronary artery disease (CAD) before a percutaneous coronary intervention (PCI). OBJECTIVE: To associate clinical variables with QoL scores in patients with stable CAD before the PCI and with unfavorable outcomes, 12 months after the procedure. METHODS: The present is a longitudinal study of 78 patients (43 men and 35 women), before an elective PCI. The associations between the QoL scores (SF-36 questionnaire) and age, sex, weight, body mass index, diabetes mellitus (DM), arterial hypertension, dyslipidemia, current smoking, previous cardiovascular event or PCI, glycemia control and blood pressure (BP) were analyzed by multivariate logistic regression. We also analyzed the associations between the clinical features and the unfavorable outcomes (death due to any cause, heart failure or nonfatal infarction). The level of significance was set at p &lt; 0.05. RESULTS: The medians of the QoL scores were &lt; 70 percentage in all domains. Female sex, age &lt; 60 years, previous cardiovascular event or PCI, BMI &gt; 25 kg/m&#178;, DM and high BP were associated with a higher degree of impairment of at least one QoL score. Female sex (OR: 7.19; 95%CI: 1.55 - 33.36; p = 0.012), previous cardiovascular event (OR: 3.97; 95%CI: 1.01 - 15.66; p = 0.049) and PCI failure (OR: 10.60; 95%CI: 1.83 - 61.46; p = 0.008) were associated with increased risk of combined outcome. CONCLUSION: In the presence of CAD, women and patients with comorbidities present a higher degree of QoL impairment. The unfavorable outcomes 12 months after the PCI are associated with the female sex, previous event or procedure failure.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <kwd>Quality of life</kwd>
        <kwd>depression</kwd>
        <kwd>coronary artery disease</kwd>
        <kwd>women</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>ORIGINAL ARTICLE</bold>
      </p>
      <p>
        <fn id="top-body2">
          <label>
            <bold>Quality of life in patients with severe and stable coronary atherosclerotic disease</bold>
          </label>
          <p>
            <bold>Gisele Moriel<sup>I</sup>; Meliza Goi Roscani<sup>II</sup>; Luiz Shiguero Matsubara<sup>II</sup>; Ana Teresa de A. Ramos Cerqueira<sup>II</sup>; Beatriz Bojikian Matsubara<sup>II</sup></bold>
          </p>
        </fn>
      </p>
      <p><sup>I</sup>Hospital Santa Marcelina, S&#227;o Paulo, SP - Brazil</p>
      <p><sup>II</sup>Faculdade de Medicina de Botucatu - UNESP, S&#227;o Paulo, SP - Brazil</p>
      <p>Mailing address</p>
      <p>
        <bold>ABSTRACT</bold>
      </p>
      <p><bold>BACKGROUND: </bold> There are few data on the factors decreasing quality of life (QoL) in patients with coronary artery disease (CAD) before a percutaneous coronary intervention (PCI).</p>
      <p><bold>OBJECTIVE: </bold> To associate clinical variables with QoL scores in patients with stable CAD before the PCI and with unfavorable outcomes, 12 months after the procedure.</p>
      <p><bold>METHODS: </bold> The present is a longitudinal study of 78 patients (43 men and 35 women), before an elective PCI. The associations between the QoL scores (SF-36 questionnaire) and age, sex, weight, body mass index, diabetes mellitus (DM), arterial hypertension, dyslipidemia, current smoking, previous cardiovascular event or PCI, glycemia control and blood pressure (BP) were analyzed by multivariate logistic regression. We also analyzed the associations between the clinical features and the unfavorable outcomes (death due to any cause, heart failure or nonfatal infarction). The level of significance was set at p &lt; 0.05.</p>
      <p><bold>RESULTS: </bold> The medians of the QoL scores were &lt; 70 percentage in all domains. Female sex, age &lt; 60 years, previous cardiovascular event or PCI, BMI <underline>&gt;</underline> 25 kg/m&#178;, DM and high BP were associated with a higher degree of impairment of at least one QoL score. Female sex (OR: 7.19; 95%CI: 1.55 - 33.36; p = 0.012), previous cardiovascular event (OR: 3.97; 95%CI: 1.01 - 15.66; p = 0.049) and PCI failure (OR: 10.60; 95%CI: 1.83 - 61.46; p = 0.008) were associated with increased risk of combined outcome.</p>
      <p><bold>CONCLUSION: </bold> In the presence of CAD, women and patients with comorbidities present a higher degree of QoL impairment. The unfavorable outcomes 12 months after the PCI are associated with the female sex, previous event or procedure failure. (Arq Bras Cardiol 2010;95(6):691-697)</p>
      <p><bold>Keywords:</bold> Quality of life; depression; coronary artery disease; women.</p>
      <p>
        <bold>Introduction</bold>
      </p>
      <p>Lifestyle and emotional stress are risk factors for cardiovascular diseases that have been emphasized in the literature. Studies have shown a higher incidence of cardiovascular events among the population with depressive symptoms or low scores of quality of life (QoL) indicators. Additionally, patients with established coronary artery disease (CAD) present QoL impairment and high levels of stress, caused by the disease itself, physical limitation and risk of death, closing a vicious circle that intensifies the disease progression<sup>1-4</sup>. It is believed that, in addition to disease severity, the association of comorbidities, such as diabetes mellitus (DM), arterial hypertension (AH) and obesity, frequently observed in these patients, could represent an aggravating factor for the decline in QoL<sup>5</sup>.</p>
      <p>The global definition of quality of life takes into account the individual's external life conditions and subjective experiences<sup>6</sup>. IT is not an easy task to quantify quality of life. Several tools have been proposed for that purpose, which have been validated by several studies. The assessment of the health status by the Seattle Angina Questionnaire (SAQ)<sup>7</sup> is one of these methods used to evaluate QoL related to the limitations in activities of daily living caused by the intensity of angina, as well as the satisfaction with the performed treatment. A more comprehensive questionnaire and better applied to patients with chronic diseases, including CAD, is the Medical Outcomes Study 36-item Short-form Health Survey(SF-36)<sup>1,8-10</sup>, which has been translated to Brazilian Portuguese and validated in Brazil<sup>11</sup>.</p>
      <p>Norris et al<sup>12</sup> evaluated 3,392 patients with CAD, one year after the hemodynamic study, using the SAQ and observed that women, when compared to men, presented QoL impairment regarding several indices, such as lower level of satisfaction with the performed treatment higher frequency of angina episodes and lower physical exercise capacity.</p>
      <p>Another study<sup>13</sup> showed that women older than 65 years with symptoms of depression presented an unfavorable clinical evolution, with worse prognosis, six months after a cardiovascular event.</p>
      <p>In our country, Favorato et al<sup>14</sup> described a higher degree of QoL impairment in women with CAD after clinical or surgical treatment or percutaneous coronary intervention (PCI), when compared to men. These results were consistent with the Rita-2 study<sup>15</sup>, which included a large sample and also identified the female sex as a factor associated with QoL impairment in patients with CAD.</p>
      <p>As the national literature has scarce data on this aspect, the objective of the present study was to associate clinical variables and QoL scores in patients with severe and stable CAD, before the PCI and evaluate unfavorable outcomes, 12 months after the procedure.</p>
      <p>
        <bold>Methods</bold>
      </p>
      <p>All procedures were submitted to appreciation and were approved by the Ethics Committee in Research of <bold><italic>Faculdade de Medicina de Botucatu</italic></bold> - UNESP (OF.78/2005-CEP). There were no sources of funding for this research.</p>
      <p>A longitudinal, prospective study was carried out in a population of patients referred to undergo PCI. A total of 78 patients of both sexes, older than 18 years and no other age limitations, with a diagnosis of CAD, regardless of a previous diagnosis of acute myocardial infarction (AMI) and submitted to angioplasty of one or more coronary arteries, during an elective procedure that was scheduled in advance, were included in the study. All agreed to participate and signed the Free and Informed Consent Form. These patients were referred by the regional Cardiology Outpatient Clinics, from August 2004 to June 2006. All patients were submitted to a thorough clinical-cardiological evaluation.</p>
      <p>The following exclusion criteria were adopted: 1) hemodynamic instability, characterized by a systolic pressure &lt; 100 mmHg and/or dyspnea at rest, precordial pain at the assessment, severe arrhythmia; 2) patients with a diagnosis of acute ischemic syndrome.</p>
      <p>
        <bold>Clinical evaluation</bold>
      </p>
      <p>The demographic and clinical variables were: origin, marital status, sex, degree of schooling, occupational status, age, previous history of AMI or other cardiovascular event (acute ischemic syndrome, peripheral artery disease or cerebrovascular accident), diabetes mellitus, arterial hypertension or smoking, number of coronary arteries with severe lesions (&gt; 70% of lumen obstruction), weight, height, body mass index, blood pressure. After the angioplasty, the following variables were considered: coronary artery submitted to the procedure and the result of angioplasty (the success of the procedure was defined as TIMI 3 flow in the artery submitted to PCI).</p>
      <p>The laboratory variables were: fasting glycemia, total cholesterol and fractions, triglycerides, urea, serum creatinine, hematocrit and hemoglobin.</p>
      <p>The following values were adopted to define the control of risk factors: systolic blood pressure &lt; 140 mmHg and diastolic blood pressure &lt; 90 mmHg (in diabetic patients, these values were decreased to 130 and 80 mmHg, respectively); fasting glycemia <underline>&lt;</underline> 126 mg/dl; LDL-cholesterol <underline>&lt;</underline> 100 mg/dl; BMI &lt; 25 kg/m&#178;; and triglycerides <underline>&lt;</underline> 150 mg/dl<sup>13, 16,17</sup>.</p>
      <p>
        <bold>Quality of life assessment</bold>
      </p>
      <p>The standard SF-36 questionnaire was applied, always by the same interviewer, at the hospital facility, in a room specially prepared for this purpose, in a calm, silent and private environment. This tool contains 36 items that encompass 8 domains: functional capacity (10 items); physical performance (4 items); pain (2 items); general health status (5 items); vitality (4 items); social aspects (2 items); emotional aspects (3 items) and mental health (5 items). Based on the answers obtained, the QoL scores were calculated, following the literature recommendations<sup>6,7,18</sup>.</p>
      <p>The medians of the score values were considered as reference to categorize the "highest" and "lowest" scores in each aspect.</p>
      <p>
        <bold>Clinical outcomes</bold>
      </p>
      <p>Twelve months after the angioplasty, contacts by telephone were carried out and the medical files were checked for outcome. Death due to any cause, hospitalization due to heart failure (HF) or nonfatal AMI were considered "unfavorable clinical outcomes".</p>
      <p>
        <bold>Statistical analysis</bold>
      </p>
      <p>Mean values, with their respective standard deviations, were calculated for continuous variables with normal distribution. The QoL scores were expressed as medians and interquartile ranges. The univariate exploratory analysis was carried out by Student's <bold><italic>t</italic></bold> test or Mann-Whitney test. The differences between proportions were analyzed by Chi-square test. The associations with a probability of being due to chance &lt; 0.20 were introduced in the multivariate logistic regression model.</p>
      <p>The multivariate logistic regression analysis was applied to identify which clinical features were associated with the categorized QoL score impairment. In this analysis, the "highest" or "lowest" category was considered as the dependent variable in each of the 8 studied items. The following independent variables were categorized and included in the model: sex (male and female), age (<underline>&gt;</underline> 60 years or &lt; 60 years), BMI (&lt; 25 kg/m&#178; or <underline>&gt;</underline> 25 kg/m&#178;), diabetes mellitus (yes/no), increased fasting glycemia (yes/no), previous cardiovascular event (yes/no), previous angioplasty (yes/no), current smoker (yes/no). The following continuous variables were also included: systolic blood pressure (SBP) and diastolic blood pressure (DBP).</p>
      <p>The same analysis was carried out to identify which clinical features were associated with a combined clinical outcome.</p>
      <p>In all cases, the level of significance was set at p &lt; 0.05.</p>
      <p>
        <bold>Results</bold>
      </p>
      <p>Thirty-five patients from the study sample were females and 43 were males. <xref ref-type="table" rid="t1-body2">Table 1</xref> shows the means and standard deviations of age, weight, height, blood pressure and biochemical variables. The distribution of QoL scores is shown in <xref ref-type="fig" rid="f1-body2">Figure 1</xref>. The medians and interquartile ranges of the scores in the eight domains were: 65; 40-85 (functional capacity); 25, 0-50 (physical aspects); 52, 30-72 (pain); 62, 47-77 (general health status); 62, 45-75 (vitality); 50, 37-100 (social aspects); 67, 33-100 (emotional aspects); and 66, 40-80 (mental health).</p>
      <table-wrap id="t1-body2">
        <graphic xlink:href="1678-4170-abc-95-06-0691-00151-gt01-en.jpg"/></table-wrap>
      <fig id="f1-body2">
        <graphic xlink:href="1678-4170-abc-95-06-0691-00151-gf01-en.jpg"/></fig>
      <p><xref ref-type="table" rid="t2-body2">Table 2</xref> shows the medians and 25<sup>th</sup> and 75<sup>th</sup> percentiles of the scores in the eight domains of the SF-36 questionnaire, in men and women.</p>
      <table-wrap id="t2-body2">
        <graphic xlink:href="1678-4170-abc-95-06-0691-00151-gt02-en.jpg"/></table-wrap>
      <p>The significant associations between the several aspects of the QoL scores and the clinical variables were:</p>
      <p><italic>1. Functional capacity</italic><bold><italic>-</italic></bold> age <underline>&gt;</underline> 60 years (OR: 0.18; 95%CI: 0.05 to 0.72; p = 0.04) and male sex (OR: 0.18; 95%CI<sub>:</sub> -3.0 to -0.44; p = 0.009) were protective factors, decreasing the risk of QoL score impairment. Higher SBP (143 &#177; 23 mmHg <bold><italic>vs</italic></bold> 133 &#177; 16 mmHg; p = 0.032) and BMI &gt; 25 kg/m&#178; were associated with lower scores (OR: 1.05; 95%CI: 0.01-0.09; p = 0.01 and OR: 3.8; 95%CI: 1.06-13.8; p = 0.04, respectively).</p>
      <p><italic>2. Physical aspects</italic><bold><italic>-</italic></bold> the only variable independently associated to a lower QoL score was the presence of previous cardiovascular event (OR: 3.7; 95%CI: 1.2-11.4; p = 0.02).</p>
      <p><italic>3. Pain</italic><bold><italic> -</italic></bold> only the male sex showed to be a protective factor and was associated with higher scores in this item (OR: 0.26; 95%CI: 0.08-0.78; p = 0.017).</p>
      <p><italic>4. General health status</italic><bold><italic>-</italic></bold> the presence of DM and previous cardiovascular event were significantly associated with additional QoL impairment (OR: 11.2; 95%CI: 1.29-97.8; p = 0.028 and OR: 5.6; 95%CI: 1.4-22.7; p = 0.015, respectively).</p>
      <p><italic>5. Vitality</italic><bold><italic> -</italic></bold> none of the variables included in the logistic regression model was independently associated with additional QoL score impairment in the studied sample.</p>
      <p><italic>6. Social aspects</italic><bold><italic> -</italic></bold> previous PCI was associated with lower scores (OR: 103; 95%CI: 3.9-33.1; p = 0.001).</p>
      <p><italic>7. Emotional aspects</italic><bold><italic>-</italic></bold> no clinical variable was shown to significantly contribute to the modification of the score.</p>
      <p><italic>8. Mental health</italic><bold><italic> -</italic></bold> the male sex was associated with a lower risk of decrease in this domain (OR: 0.21; 95%CI: 0.06-0.71; p = 0.01). Previous PCI and overweight/obesity contributed to the impairment of this variable (OR: 3.3; 95%CI: 1.08-10.07; p = 0.035 and OR: 4.3; 95%CI: 1.19-15.85; p = 0.02, respectively).</p>
      <p>Twelve months after the procedure, complete data were obtained regarding 74 individuals. Four cases were excluded due to lack of data in the medical files and failure to establish telephone contact. During this period, 13 of the 74 stents presented re-stenoses identified at a new coronary angiography. New interventions were carried out in 11 vessels.</p>
      <p>Seventeen patients presented at least one of the unfavorable clinical outcomes. Five patients died; 7 needed hospitalization due to HF and 10 presented nonfatal AMI.</p>
      <p>The female sex (OR: 7.19; 95%CI: 1.55-33.36; p = 0.012), previous cardiovascular event (OR: 3.97; 95%CI 1.01-15.66; p = 0.049) and PCI failure (OR: 10.60; 95%CI: 1.83-61.46; p = 0.008) were associated with increased risk of combined outcome.</p>
      <p>
        <bold>Discussion</bold>
      </p>
      <p>The present study aimed at evaluating the factors associated with QoL impairment in patients with severe and stable CAD. The associations between clinical features and unfavorable outcomes after the angioplasty were also analyzed.</p>
      <p>The study population was characteristically elderly, overweight and without ideal control of modifiable cardiovascular risk factors. This finding is relevant, considering that such patients already presented target-organ lesions. Lack of ideal BP control was identified in 51.0% of the patients; of glycemia, in 44.0% and of the lipid profile, in 68.0% of the patients. Additionally, 36 cases presented overweight and 14 cases presented obesity.</p>
      <p>The difficulty to control all cardiovascular risk factors is often described in the literature<sup>19</sup>. A survey carried out by Ministry of Health and Pan-American Health Organization, called "Evaluation of the Reorganization Plan for Arterial Hypertension and Diabetes Mellitus Care in Brazil" showed that 36.0% of the surveyed individuals presented BP levels <underline>&gt;</underline> 140 x 90 mmHg; 16.4% of the individuals presented altered glycemia levels. The nutritional status, evaluated through the BMI, showed that 30.8% of them were overweight (BMI &gt; 25 and &lt; 30 kg/m<sup>2</sup>) and that 19.4% were obese (BMI &gt; 30.0 kg/m<sup>2</sup>)<sup>20</sup>.</p>
      <p>In the present study sample, the QoL scores were decreased in all items, taking into account the values obtained in normal individuals and described in the literature<sup>21-23</sup>. The values observed in the present study are similar to those observed by other national authors that evaluated patients with CAD<sup>1</sup>. The item physical aspects showed to be especially impaired, with 50.0% of the patients presenting a score &lt; 50. Our data do not allow us to conclude on all the causes for this alteration, but they would be in accordance with the study by Spertus et al<sup>4</sup>, who described disease-related functional status impairment in patients with DAC and symptoms of depression.</p>
      <p>The women presented lower functional capacity, in addition to reporting more pain and presenting a higher degree of mental health impairment. There have been reports in the literature showing that women present a higher degree of mental health impairment during the disease<sup>24-26</sup>. This characteristic might be associated to women's higher capacity of verbalization during the assessment<sup>27</sup>. It might also be associated with social-cultural factors, which implicate in longer working hours, prejudice and other factors.</p>
      <p>It is noteworthy the observation that individuals aged <underline>&gt;</underline> 60 reported better functional capacity. A possible explanation for this result might be the highest impact of the disease on younger individuals, that is, patients who were previously more active, when compared to already retired and less active patients, can experience more difficulty with the imposed rest or work incapacity.</p>
      <p>The other variables associated with QoL score impairment, in fact, reflect the presence of comorbidities or older or more severe CAD. The presence of DM, uncontrolled arterial hypertension, overweight/obesity and repeated cardiovascular events are conditions that contribute to aggravate the health status and affect the individuals' daily activities<sup>28</sup>.</p>
      <p>Therefore, although the results obtained were expected, it is noteworthy the small number of references in the literature that addressed this aspect in the specific case of patients with coronary atherosclerotic disease. Miralda et al<sup>26</sup> evaluated patients after myocardial revascularization surgery and observed that the presence of multiple risk factors and the female sex were associated with QoL impairment. In a subsequent study, these authors identified preserved QoL in the patients after angioplasty<sup>27</sup>.</p>
      <p>Differently, the present study did not evaluate the association between QoL scores and outcomes after the angioplasty, as its objective was to assess the QoL score impairment in patients with CAD before the procedure.</p>
      <p>One aspect that deserves to be discussed is the possible implication of QoL impairment and depression symptoms on these patients' prognosis. Three physiopathological mechanisms can be involved<sup>29</sup>. First, the depression might be accompanied by hypercortisolemia, a well-known pro-atherosclerotic component<sup>30</sup>. Second, depressive individuals might present higher platelet aggregation and pro-inflammatory component release<sup>31</sup>. Finally, they can also present lower HR variability and decreased vagal tonus, favoring a higher incidence of arrhythmogenic events<sup>32,33</sup>. There is an increase in blood pressure, vasoconstriction and endothelial dysfunction, thus accelerating atherosclerotic phenomena<sup>34,35</sup>.</p>
      <p>It is noteworthy the observation of a higher risk of combined outcome in women, patients with previous cardiovascular event or PCI failure, even in a relatively small sample, such as this one. Previous events and procedure failure are easy-to-understand factors, considering the fact that they represent a more severe disease. On the other hand, the question of a higher risk for the female sex must be better analyzed, as it is less understood.</p>
      <p>Several factors can explain the association between the female sex and a higher risk of unfavorable cardiovascular outcome. In general, women with CAD are older and present a higher number of comorbidities<sup>36</sup>. Several mechanisms have been implicated, such as the post-menopausal decrease in estrogen secretion. Estrogen is the factor responsible for the delay in the atherosclerotic activity during the fertile age in women, with the increase in HDL levels and cardiovascular protection. An interesting aspect is that women also present a higher risk of QoL impairment.</p>
      <p>This observation might suggest that the two phenomena are related. That is, the higher risk of events in women might be associated, in part, to the fact that they present more depressive symptoms and a poorer psychosocial adjustment in the presence of a cardiovascular event<sup>11</sup>. However, the association between QoL impairment and unfavorable outcomes was not assessed in the present study. That was due to the fact that the PCI was performed after the definition of the scores, which might constitute an interpretation bias. In spite of that, it is noteworthy the evidence that women presenting depressive symptoms and a lower degree of social integration also present a higher risk of unfavorable clinical outcomes in the presence of CAD<sup>37,38</sup>. Moreover, poor QoL and emotional stress would cause ovarian dysfunction, lower estrogen secretion, neuroendocrine activation and hypercortisolemia, accelerating the atherosclerotic process<sup>39,40</sup>, closing the vicious circle.</p>
      <p>
        <bold>Conclusion</bold>
      </p>
      <p>Quality of life is impaired in patients with severe and stable CAD. This impairment is aggravated in women and patients with other comorbidities, such as DM, overweight, obesity, uncontrolled hypertension and previous cardiovascular event or PCI. Twelve months after the PCI, there was a higher risk of unfavorable outcomes in women and patients with previous cardiovascular event or PCI procedure failure.</p>
      <p>
        <bold>Potential Conflict of Interest</bold>
      </p>
      <p>No potential conflict of interest relevant to this article was reported.</p>
      <p>
        <bold>Sources of Funding</bold>
      </p>
      <p>There were no external funding sources for this study.</p>
      <p>
        <bold>Study Association</bold>
      </p>
      <p>This study is not associated with any post-graduation program.</p>
      <p>
        <bold>References</bold>
      </p>
    </body>
  </sub-article>
  <sub-article article-type="translation" id="TRes" xml:lang="es">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Art&#237;culos Originales</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="es">Calidad de vida en pacientes con enfermedad ateroscler&#243;tica coronaria severa y estable</article-title>
      </title-group>
      <abstract xml:lang="es">
        <p>FUNDAMENTO: Hay pocas informaciones sobre factores agravantes de la calidad de vida en pacientes con enfermedad arterial coronaria (EAC), antes de la intervenci&#243;n coronaria percut&#225;nea (ICP). OBJETIVOS: Asociar variables cl&#237;nicas con scores de calidad de vida (ECV) en pacientes con CAC estable, antes de la ICP y con desenlaces desfavorables, 12 meses tras el procedimiento. M&#201;TODOS: Se trata de estudio longitudinal incluyendo a 78 pacientes (43 varones y 35 mujeres), antes de la ICP electiva. Las asociaciones entre ECV (cuestionario SF-36) y edad, sexo, peso, &#237;ndice de masa corp&#243;rea, diabetes melito (DM), hipertensi&#243;n arterial, dislipidemia, tabaquismo actual, evento cardiovascular o ICP previos, control de glucemia y de la presi&#243;n arterial se analizaron por medio de regresi&#243;n log&#237;stica multivariada. Tambi&#233;n se analizaron las asociaciones entre estos atributos cl&#237;nicos y los desenlaces desfavorables (muerte por cualquier causa, insuficiencia cardiaca o infarto no fatal). El nivel de significancia fue p &lt; 0,05. RESULTADOS: Las medianas de los ECV estuvieran abajo de 70 en todos los dominios. Sexo femenino, edad &lt; 60 a&#241;os, evento cardiovascular o ICP previos, IMC &gt; 25 kg/m&#178;, DM y presi&#243;n arterial elevada se asociaron a mayor perjuicio de, al menos uno de los ECV. Sexo femenino (OR: 7,19; IC95%: 1,55 - 33,36; p = 0,012), evento cardiovascular previo (OR: 3,97; IC95%: 1,01 - 15,66; p = 0,049) y sin &#233;xito en la ICP (OR: 10,60; IC95%: 1,83 - 61,46; p = 0,008) se asociaron con riesgo aumentado de desenlace combinado. CONCLUSI&#211;N: En la presencia de EAC, mujeres y pacientes con comorbidades tiene mayor perjuicio de la calidad de vida. Los desenlaces desfavorables tras 12 meses de la ICP est&#225;n asociados con el sexo femenino, evento previo o sin &#233;xito del procedimiento.</p>
      </abstract>
      <kwd-group xml:lang="es">
        <kwd>Depresi&#243;n</kwd>
        <kwd>ansiedad</kwd>
        <kwd>enfermedad arterial coronaria</kwd>
        <kwd>sexo femenino</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>ART&#205;CULO ORIGINAL</bold>
      </p>
      <p>
        <fn id="top-body3">
          <label>
            <bold>Calidad de vida en pacientes con enfermedad ateroscler&#243;tica coronaria severa y estable</bold>
          </label>
          <p>
            <bold>Gisele Moriel<sup>I</sup>; Meliza Goi Roscani<sup>II</sup>; Luiz Shiguero Matsubara<sup>II</sup>; Ana Teresa de A. Ramos Cerqueira<sup>II</sup>; Beatriz Bojikian Matsubara<sup>II</sup></bold>
          </p>
        </fn>
      </p>
      <p><sup>I</sup>Hospital Santa Marcelina, S&#227;o Paulo, SP - Brasil</p>
      <p><sup>II</sup>Faculdade de Medicina de Botucatu - UNESP, S&#227;o Paulo, SP - Brasil</p>
      <p>Correspondencia</p>
      <p>
        <bold>RESUMEN</bold>
      </p>
      <p><bold>FUNDAMENTO: </bold> Hay pocas informaciones sobre factores agravantes de la calidad de vida en pacientes con enfermedad arterial coronaria (EAC), antes de la intervenci&#243;n coronaria percut&#225;nea (ICP).</p>
      <p><bold>OBJETIVOS: </bold> Asociar variables cl&#237;nicas con scores de calidad de vida (ECV) en pacientes con CAC estable, antes de la ICP y con desenlaces desfavorables, 12 meses tras el procedimiento.</p>
      <p><bold>M&#201;TODOS: </bold> Se trata de estudio longitudinal incluyendo a 78 pacientes (43 varones y 35 mujeres), antes de la ICP electiva. Las asociaciones entre ECV (cuestionario SF-36) y edad, sexo, peso, &#237;ndice de masa corp&#243;rea, diabetes melito (DM), hipertensi&#243;n arterial, dislipidemia, tabaquismo actual, evento cardiovascular o ICP previos, control de glucemia y de la presi&#243;n arterial se analizaron por medio de regresi&#243;n log&#237;stica multivariada. Tambi&#233;n se analizaron las asociaciones entre estos atributos cl&#237;nicos y los desenlaces desfavorables (muerte por cualquier causa, insuficiencia cardiaca o infarto no fatal). El nivel de significancia fue p &lt; 0,05.</p>
      <p><bold>RESULTADOS: </bold> Las medianas de los ECV estuvieran abajo de 70 en todos los dominios. Sexo femenino, edad &lt; 60 a&#241;os, evento cardiovascular o ICP previos, IMC <underline>&gt;</underline> 25 kg/m&#178;, DM y presi&#243;n arterial elevada se asociaron a mayor perjuicio de, al menos uno de los ECV. Sexo femenino (OR: 7,19; IC<sub>95%</sub>: 1,55 - 33,36; p = 0,012), evento cardiovascular previo (OR: 3,97; IC<sub>95%</sub>: 1,01 - 15,66; p = 0,049) y sin &#233;xito en la ICP (OR: 10,60; IC<sub>95%</sub>: 1,83 - 61,46; p = 0,008) se asociaron con riesgo aumentado de desenlace combinado.</p>
      <p><bold>CONCLUSI&#211;N: </bold> En la presencia de EAC, mujeres y pacientes con comorbidades tiene mayor perjuicio de la calidad de vida. Los desenlaces desfavorables tras 12 meses de la ICP est&#225;n asociados con el sexo femenino, evento previo o sin &#233;xito del procedimiento. </p>
      <p><bold>Palabras clave: </bold> Depresi&#243;n, ansiedad, enfermedad arterial coronaria, sexo femenino.</p>
      <p>
        <bold>Introducci&#243;n</bold>
      </p>
      <p>Estilo de vida y estr&#233;s emocional son factores de riesgo para enfermedades cardiovasculares que tienen merecido destaque en la literatura. Estudios mostraron una mayor incidencia de eventos cardiovasculares en la poblaci&#243;n con s&#237;ntomas depresivos o bajos scores de indicadores de calidad de vida. Adem&#225;s de ello, pacientes con enfermedad ateroscler&#243;tica coronaria (EAC) ya instalada presentan calidad de vida perjudicada y nivel elevado de estr&#233;s, impuestos por la propia condici&#243;n de enfermedad, limitaci&#243;n f&#237;sica y riesgo de muerte, cerrando un c&#237;rculo vicioso que intensifica la progresi&#243;n de la enfermedad<sup>1, 2-4</sup>. Se presume que, adem&#225;s de la severidad de la enfermedad, la asociaci&#243;n de comorbidades, como diabetes melito (DM), hipertensi&#243;n arterial (HA) y obesidad, frecuentemente presentes en estos pacientes, podr&#237;a representar un agravante en el descenso de la calidad de vida<sup>5</sup>.</p>
      <p>La definici&#243;n global de calidad de vida tiene en cuenta las condiciones externas de vida y las experiencias subjetivas del individuo<sup>6</sup>. No es tarea f&#225;cil cuantificar la calidad de vida. Para tanto, hay varias propuestas de instrumentos que fueron validadas por diversos estudios. La evaluaci&#243;n del estado de salud por el Cuestionario de Angina de Seattle (CAS)<sup>7</sup> es una metodolog&#237;a utilizada para evaluarse la calidad de vida relacionada a las limitaciones en las actividades diarias proporcionadas por la intensidad de la angina, as&#237; como la satisfacci&#243;n con el tratamiento realizado. Un cuestionario m&#225;s amplio y m&#225;s bien aplicado a pacientes con enfermedades cr&#243;nicas, incluyendo la EAC es el <italic>Medical Outcomes Study 36-item Short-form Health Survey (SF-36)</italic><sup>1, 8-10</sup>, traducido y validado en el Brasil<sup>11</sup>.</p>
      <p>Norris et al<sup>12</sup> evaluaron a 3.392 pacientes con EAC, un a&#241;o despu&#233;s del estudio hemodin&#225;mico, utilizando el cuestionario CAS, y observaron que las mujeres, con relaci&#243;n al sexo masculino, presentaron perjuicio en los &#237;ndices de calidad de vida en varios quesitos, tales como: menor satisfacci&#243;n con el tratamiento realizado, mayor frecuencia de los episodios de angina y menor capacidad para ejercicio f&#237;sico.</p>
      <p>Otro estudio<sup>13</sup> evidenci&#243; que mujeres arriba de 65 a&#241;os y con s&#237;ntomas depresivos presentaban evoluci&#243;n cl&#237;nica desfavorable, con empeoramiento pron&#243;stico, 6 meses tras evento cardiovascular.</p>
      <p>En nuestro medio, Favorato et al<sup>14</sup> describieron perjuicio m&#225;s acentuado de la calidad de vida en mujeres con EAC, tras tratamiento cl&#237;nico, quir&#250;rgico o ICP, cuando comparadas a los varones. Estos resultados fueron consistentes con el estudio Rita-2<sup>15</sup>, que incluy&#243; casu&#237;stica numerosa y que tambi&#233;n identific&#243; el g&#233;nero femenino como factor asociado al empeoramiento de la calidad de vida en pacientes con EAC.</p>
      <p>Una vez que la literatura nacional es pobre en informaciones sobre dicho aspecto, el objetivo del presente estudio fue asociar variables cl&#237;nicas y scores de calidad de vida (ECV) en pacientes con EAC severa y estable, antes de la ICP, y evaluar desenlaces desfavorables, 12 meses tras procedimiento.</p>
      <p>
        <bold>M&#233;todos</bold>
      </p>
      <p>Todos los procedimientos se sometieron a apreciaci&#243;n, siendo aprobados por el Comit&#233; de &#201;tica en Investigaci&#243;n de la Facultad de Medicina de Botucatu - UNESP (OF.78/2005-CEP). No hubo fuentes de financiaci&#243;n para esta investigaci&#243;n.</p>
      <p>Se llev&#243; a cabo estudio prospectivo longitudinal en una poblaci&#243;n de pacientes enviados para llevar a cabo ICP.</p>
      <p>Se incluyeron a 78 pacientes de ambos sexos, mayores de 18 a&#241;os y sin otros l&#237;mites de edad, con diagn&#243;stico de EAC, independiente de diagn&#243;stico previo de infarto agudo de miocardio (IAM) y sometidos a angioplastia de una o m&#225;s arterias coronarias, en procedimiento electivo y marcado con antelaci&#243;n. Todos concordaron con participar y firmaron el formulario de consentimiento informado. Estos pacientes fueron enviados por los ambulatorios regionales de cardiolog&#237;a, en el per&#237;odo de agosto de 2004 a junio de 2006. Todos los pacientes pasaron por evaluaci&#243;n cl&#237;nica cardiol&#243;gica completa.</p>
      <p>Se adoptaron los siguientes criterios de exclusi&#243;n: 1 - inestabilidad hemodin&#225;mica, caracterizada por presi&#243;n sist&#243;lica menor que 100 mmHg y/o disnea de reposo, dolor precordial en el momento de la evaluaci&#243;n, arritmias severas; 2 - pacientes con diagn&#243;stico de s&#237;ndrome isqu&#233;mico agudo.</p>
      <p>
        <bold>Evaluaci&#243;n cl&#237;nica</bold>
      </p>
      <p>Las variables demogr&#225;ficas y cl&#237;nicas fueron: procedencia, situaci&#243;n conyugal, sexo, escolaridad, situaci&#243;n con relaci&#243;n a la ocupaci&#243;n, edad, historia previa de IAM u otro evento cardiovascular (s&#237;ndrome isqu&#233;mico agudo, enfermedad arterial perif&#233;rica, o accidente vascular encef&#225;lico), diabetes melito, hipertensi&#243;n arterial o tabaquismo, n&#250;mero de arterias coronarias con lesi&#243;n severa (&gt; 70% de obstrucci&#243;n de luz), peso, altura, &#237;ndice de masa corp&#243;rea, presi&#243;n arterial. Tras la angioplastia, se consideraron las siguientes variables: arteria coronaria sometida al procedimiento y resultado de la angioplastia (el &#233;xito en el procedimiento se defini&#243; como flujo TIMI 3 en la arteria sometida a la ICP).</p>
      <p>Las variables laboratoriales fueron: glucemia de ayuno, colesterol total y fracciones, triglic&#233;ridos, urea, creatinina s&#233;rica, hematocrito y hemoglobina.</p>
      <p>Se adoptaron los siguientes valores para definici&#243;n de control de los factores de riesgo: presi&#243;n arterial sist&#243;lica &lt; 140 mmHg y diast&#243;lica &lt; 90 mmHg (en pacientes diab&#233;ticos, estos valores se redujeron para 130 y 80 mmHg, respectivamente); glucemia de ayuno <underline>&lt;</underline> 126 mg/dL; LDL-colesterol <underline>&lt;</underline> 100 mg/dL; IMC &lt; 25 kg/m&#178;; y triglic&#233;ridos <underline>&lt;</underline> 150 mg/dL<sup>13, 16-17</sup>.</p>
      <p>
        <bold>Evaluaci&#243;n de la calidad de vida</bold>
      </p>
      <p>Se aplic&#243; el cuestionario est&#225;ndar SF-36, siempre por la misma entrevistadora, en las dependencias del HC, en sala espec&#237;ficamente destinada para este fin, en ambiente calmo, silencioso y privativo. Este instrumento contiene 36 &#237;tems que engloban 8 dominios: Capacidad Funcional (10 &#237;tems); Desempe&#241;o F&#237;sico (4 &#237;tems); Dolor (2 &#237;tems); Estado General de Salud (5 &#237;tems); Vitalidad (4 &#237;tems); Aspectos Sociales (2 &#237;tems); Aspectos Emocionales (3 &#237;tems); y Salud Mental (5 &#237;tems). A partir de las respuestas obtenidas, se calcularon los scores de calidad de vida, seg&#250;n la recomendaci&#243;n de la literatura<sup>6, 7, 18</sup>.</p>
      <p>Las medianas de los valores de los scores se tomaron como referencia para categorizaci&#243;n de los scores "mayores" y "menores", en cada aspecto.</p>
      <p>
        <bold>Desenlaces cl&#237;nicos</bold>
      </p>
      <p>Tras 12 meses de la realizaci&#243;n de la angioplastia, fueron realizados contactos por tel&#233;fono y consultas a los prontuarios m&#233;dicos para el registro de desenlaces. Se llevaron a cabo como "desenlaces cl&#237;nicos desfavorables": defunci&#243;n por cualquier causa, internaci&#243;n por insuficiencia cardiaca (IC) o IAM no fatal.</p>
      <p>
        <bold>An&#225;lisis estad&#237;stico</bold>
      </p>
      <p>Se calcularon los valores promedios, con las respectivas desviaciones-est&#225;ndares para variables continuas y con distribuci&#243;n normal. Los ECV fueron expresos como medianas y amplitudes intercuartilicas. El an&#225;lisis exploratorio univariado se efectu&#243; por medio de las pruebas "t" de <italic>student</italic> o de Mann-Whitney. Las diferencias entre proporciones se analizaron por la prueba del chi-cuadrado. Las asociaciones con probabilidad menor que 0,20 de deberse al azar se introdujeron en el modelo de regresi&#243;n log&#237;stica multivariada.</p>
      <p>El an&#225;lisis de regresi&#243;n log&#237;stica multivariada se aplic&#243; para identificar cuales atributos cl&#237;nicos estuvieron asociados a perjuicio de los ECV categorizados. En este an&#225;lisis, se asume como variable dependiente la categor&#237;a "mayor" o "menor", en cada uno de los 8 quesitos estudiados. Las siguientes variables independientes fueron categorizadas e incluidas en el modelo: sexo (masculino y femenino), edad (<underline>&gt;</underline> 60 a&#241;os o &lt; 60 a&#241;os), IMC (&lt; 25 kg/m&#178; &#243; <underline>&gt;</underline> 25 kg/m&#178;), diabetes melito (s&#237;/no), glucemia de ayuno aumentada (s&#237;/no), evento cardiovascular previo (s&#237;/no), angioplastia previa (s&#237;/no), tabaquismo actual (s&#237;/no). Tambi&#233;n se incluyeron las siguientes variables continuas: presi&#243;n arterial sist&#243;lica (PAS) y presi&#243;n arterial diast&#243;lica (PAD).</p>
      <p>El mismo an&#225;lisis se efectu&#243; para identificar cuales atributos cl&#237;nicos se asociaron con desenlace cl&#237;nico combinado.</p>
      <p>En todos los casos, el nivel de significancia adoptado fue p &lt; 0,05.</p>
      <p>
        <bold>Resultados</bold>
      </p>
      <p>Treinta y cinco pacientes de la casu&#237;stica estudiada eran del sexo femenino y 43 del sexo masculino. En la <xref ref-type="table" rid="t1-body3">Tabla 1</xref>, son presentados los promedios y las desviaciones-est&#225;ndar de la edad, peso, altura, presi&#243;n arterial y variables bioqu&#237;micas. La distribuci&#243;n de los ECV est&#225; ilustrada en la <xref ref-type="fig" rid="es_04f01-body3">Figura 1</xref>. Las medianas y los intervalos intercuartilicos de los scores en los 8 dominios fueron: 65; 40-85 (capacidad funcional); 25, 0-50 (aspectos f&#237;sicos); 52, 30-72 (dolor); 62, 47-77 (estado general de salud); 62, 45-75 (vitalidad); 50, 37-100 (aspectos sociales); 67, 33-100 (aspectos emocionales); y 66, 40-80 (salud mental).</p>
      <p content-type="asset">
        <fig id="es_04f01-body3">
          <graphic xlink:href="1678-4170-abc-95-06-0691-00151-gf01-es.jpg"/></fig>
      </p>
      <table-wrap id="t1-body3">
        <graphic xlink:href="1678-4170-abc-95-06-0691-00151-gt01-es.jpg"/></table-wrap>
      <p>En la <xref ref-type="table" rid="t2-body3">Tabla 2</xref>, est&#225;n detalladas las medianas y los percentiles 25 y 75 de los scores de los 8 dominios que componen el SF-36, en los varones y mujeres.</p>
      <table-wrap id="t2-body3">
        <graphic xlink:href="1678-4170-abc-95-06-0691-00151-gt02-es.jpg"/></table-wrap>
      <p>Las asociaciones significantes entre los diversos aspectos de los ECV y las variables cl&#237;nicas fueron:</p>
      <p>1 - Capacidad Funcional: edad <underline>&gt;</underline> 60 a&#241;os (OR: 0,18; IC<sub>95%</sub>: 0,05 a 0,72; p = 0,04) y sexo masculino (OR: 0,18; IC<sub>95%:</sub> -3,0 a -0,44; p = 0,009) fueron factores de protecci&#243;n reduciendo el riesgo de perjuicio de ECV. PAS m&#225;s elevada (143 &#177; 23 mmHg <italic>vs</italic> 133 &#177; 16 mmHg; p = 0,032) e IMC &gt; 25 Kg/m&#178; fueron asociados a scores m&#225;s bajos (OR: 1,05; IC<sub>95%</sub>: 0,01-0,09; p = 0,01 y OR: 3,8; IC<sub>95%</sub>: 1,06-13,8; p = 0,04, respectivamente).</p>
      <p>2 - Aspectos F&#237;sicos: la &#250;nica variable asociada de forma independiente a menor ECV fue la presencia de evento cardiovascular previo (OR: 3,7; IC<sub>95%</sub>: 1,2-11,4; p = 0,02).</p>
      <p>3 - Dolor: solamente el sexo masculino se evidenci&#243; como factor protector y asociado a scores mayores en este quesito (OR: 0,26; IC<sub>95%</sub>: 0,08-0,78; p = 0,017).</p>
      <p>4 - Estado General de Salud: la presencia de DM y evento cardiovascular previo se asociaron de forma significante al perjuicio adicional de la calidad de vida (OR: 11,2; IC<sub>95%</sub>: 1,29-97,8; p = 0,028 y OR: 5,6; IC<sub>95%</sub>: 1,4-22,7; p = 0,015, respectivamente).</p>
      <p>5 - Vitalidad: ninguna de las variables incluidas en el modelo de regresi&#243;n log&#237;stica se asoci&#243; de forma independiente con perjuicio adicional del score, en la muestra estudiada.</p>
      <p>6 - Aspectos Sociales: ICP previa se asoci&#243; con scores menores (OR: 10,3; IC<sub>95%</sub>5: 3,9-33,1; p = 0,001).</p>
      <p>7 - Aspectos Emocionales: no se identific&#243; cualquier variable cl&#237;nica contribuyendo de forma significante al cambio de este score.</p>
      <p>8 - Salud Mental: sexo masculino se asoci&#243; con menor riesgo de reducci&#243;n de este dominio (OR: 0,21; IC<sub>95%</sub>: 0,06-0,71; p = 0,01). ICP previa y sobrepeso/obesidad contribuyeron al perjuicio de esta variable (OR: 3,3; IC<sub>95%</sub>: 1,08-10,07; p = 0,035 y OR: 4,3; IC<sub>95%</sub>: 1,19-15,85; p = 0,02, respectivamente).</p>
      <p>Doce meses tras el procedimiento, se obtuvieron las informaciones completas referentes a 74 individuos. Cuatro casos se excluyeron por la falta de datos en los prontuarios m&#233;dicos y por la indisponibilidad del contacto telef&#243;nico. En este per&#237;odo, 13 de los 74 <italic>stents</italic> presentaron reestenosis identificadas en nueva coronariograf&#237;a. Se llevaron a cabo nuevas intervenciones en 11 vasos.</p>
      <p>Diecisiete pacientes presentaron, uno de los desenlaces cl&#237;nicos desfavorables como m&#237;nimo. Cinco pacientes murieron, 7 necesitaron internaci&#243;n debido a IC, 10 presentaron IAM no fatal.</p>
      <p>El sexo femenino (OR: 7,19; IC<sub>95%</sub>: 1,55 - 33,36; p = 0,012), evento cardiovascular previo (OR: 3,97; IC<sub>95%</sub>: 1,01 - 15,66; p = 0,049) y sin &#233;xito en la ICP (OR: 10,60; IC<sub>95%</sub>: 1,83 - 61,46; p = 0,008) se asociaron con riesgo aumentado de desenlace combinado.</p>
      <p>
        <bold>Discusi&#243;n</bold>
      </p>
      <p>El presente estudio tuvo por objeto evaluar los factores asociados con perjuicio de la calidad de vida en pacientes con enfermedad arterial coronaria severa y estable. Tambi&#233;n se analizaron las asociaciones entre atributos cl&#237;nicos y desenlaces desfavorables tras la angioplastia.</p>
      <p>La poblaci&#243;n incluida era caracter&#237;sticamente adulta mayor, con sobrepeso y sin control ideal de factores de riesgo cardiovascular cambiables. Este hallazgo es relevante, teniendo en vista que dichos pacientes ya presentaban lesi&#243;n de &#243;rgano-blanco. Se identific&#243; falta de control ideal de la presi&#243;n arterial en un 51% de los pacientes, de la glucemia en un 44% y del perfil lip&#237;dico en el 68%. Adem&#225;s de esto, se identificaron a 36 casos con sobrepeso y 14 casos con obesidad.</p>
      <p>Esta dificultad para controlar todos los factores de riesgo cardiovascular es frecuentemente descrita en la literatura<sup>19</sup>. En un levantamiento realizado por el Ministerio de la Salud y Organizaci&#243;n Panamericana de Salud, intitulado "Evaluaci&#243;n del Plan de Reorganizaci&#243;n de Atenci&#243;n a Hipertensi&#243;n Arterial y al <italic>Diabetes Mellitus</italic> en el Brasil", el 36% de los individuos rastreados presentaban niveles de presi&#243;n arterial mayores o iguales a 140 x 90 mmHg; un 16,4% de los individuos presentaron glucemia alterada. El estado nutricional, evaluado por medio del &#237;ndice de masa corporal, evidenci&#243; que un 30,8% presentaban sobrepeso (IMC &gt; 25 y &lt; 30 kg/m<sup>2</sup>) y que un 19,4% eran obesos (IMC &gt; 30,0 kg/m<sup>2</sup>)<sup>20</sup>.</p>
      <p>En la casu&#237;stica evaluada en este estudio, los ECV se revelaron disminuidos en todos los quesitos, llev&#225;ndose en cuenta los valores obtenidos en individuos normales y descritos en la literatura<sup>21-23</sup>. Los valores observados son similares a los observados por otros autores nacionales que evaluaron a pacientes con EAC<sup>1</sup>. Especialmente, el quesito Aspectos F&#237;sicos estuvo much&#237;simo perjudicado, con el 50% de los pacientes presentando score abajo de 50. Nuestros datos no permiten concluir sobre todas las causas de esta alteraci&#243;n, sin embargo estar&#237;an acorde al estudio de Spertus et al.<sup>4</sup>, que describieron perjuicio del estado funcional relacionado a la enfermedad en pacientes con CAD y s&#237;ntomas depresivos.</p>
      <p>Las mujeres presentaron menor capacidad funcional, adem&#225;s de referir m&#225;s dolor y tener la salud mental perjudicada. Hay relatos en la literatura de que, durante la experiencia de la enfermedad, las mujeres tienen mayor compromiso de la salud mental<sup>24-26</sup>. Puede ser que esta caracter&#237;stica est&#233; asociada a la mayor capacidad de verbalizaci&#243;n de las mujeres, durante la evaluaci&#243;n<sup>27</sup>. Tambi&#233;n puede estar asociada a factores socioculturales que implican en mayor jornada de trabajo, prejuicios y otros factores.</p>
      <p>Fue sorprendente la observaci&#243;n de que individuos con edad mayor o igual a 60 a&#241;os refirieron mejor Capacidad Funcional. Una posible explicaci&#243;n para este resultado puede ser el mayor impacto que la enfermedad f&#237;sicamente limitante causa en los individuos m&#225;s j&#243;venes. Es decir, pacientes previamente m&#225;s activos, cuando comparados con pacientes ya aposentados y menos activos, pueden experimentar mayor dificultad con la imposici&#243;n de reposo o incapacidad para el trabajo.</p>
      <p>Las dem&#225;s variables asociadas con prejuicio de los ECV, de hecho, reflejan la presencia de comorbidades o enfermedad coronaria m&#225;s antigua o m&#225;s severa. La presencia de DM, hipertensi&#243;n arterial no controlada, sobrepeso/obesidad y eventos cardiovasculares repetidos son condiciones que contribuyen al empeoramiento de salud y afectan las actividades cotidianas de los individuos<sup>28</sup>. As&#237;, aunque los resultados obtenidos se esperan, llam&#243; la atenci&#243;n el peque&#241;o n&#250;mero de referencias en la literatura que abordaran dicho aspecto en el caso espec&#237;fico de pacientes con la enfermedad ateroscler&#243;tica coronaria. Miralda et al.<sup>26</sup> evaluaron a pacientes tras cirug&#237;a de revascularizaci&#243;n mioc&#225;rdica y encontraron que la presencia de m&#250;ltiples factores de riesgo y el sexo femenino estaban relacionados a perjuicio de la calidad de vida. En publicaci&#243;n posterior, estos autores identificaron calidad de vida preservada en los pacientes tras la angioplastia<sup>27</sup>.</p>
      <p>Diferentemente, en nuestro estudio no evalu&#243; la asociaci&#243;n de los scores de calidad de vida con desenlaces tras la angioplastia, ya que tuvo por objeto evaluar el perjuicio de la calidad de vida en pacientes con EAC antes del procedimiento.</p>
      <p>Un aspecto que merece discusi&#243;n es la posible implicaci&#243;n del perjuicio de la calidad de vida y s&#237;ntomas depresivos en el pron&#243;stico de estos pacientes. Tres mecanismos fisiopatol&#243;gicos pueden estar implicados<sup>29</sup>. Primeramente, la depresi&#243;n se puede seguir de hipercortisolemia, componente pro-ateroscler&#243;tico ya bien conocido<sup>30</sup>. En segundo lugar, individuos depresivos pueden presentar mayor agregaci&#243;n plaquetaria y liberaci&#243;n de componente pro-inflamatorios<sup>31</sup>. Finalmente, pueden tambi&#233;n presentar menor variabilidad de la frecuencia card&#237;aca y tono vagal disminuido, favoreciendo la mayor incidencia de eventos arritmog&#233;nicos<sup>32, 33</sup>. Hay aumento de la presi&#243;n arterial, vasoconstricci&#243;n y disfunci&#243;n endotelial, acelerando fen&#243;menos ateroscler&#243;ticos<sup>34,35</sup>.</p>
      <p>Fue relevante la observaci&#243;n de mayor riesgo de desenlace combinado en mujeres, pacientes con evento cardiovascular previo o sin &#233;xito en la ICP, aun en una casu&#237;stica relativamente peque&#241;a como &#233;sta presentada. Evento previo y sin &#233;xito en el procedimiento son factores de f&#225;cil entendimiento, visto que reflejan la enfermedad m&#225;s severa. Por otro lado, la cuesti&#243;n de mayor riesgo en mujeres se debe analizar mejor, ya que es menos comprendida.</p>
      <p>Hay diversos factores que pueden explicar la asociaci&#243;n del sexo femenino al mayor riesgo de desenlace cardiovascular desfavorable. En general, las mujeres con EAC son m&#225;s a&#241;osas y presentan mayor n&#250;mero de comorbidades<sup>36</sup>. Diversos mecanismos se vienen implicando, como la disminuci&#243;n de secreci&#243;n de estr&#243;geno en la pos-menopausia. El estr&#243;geno es el factor responsable del retraso de la actividad ateroscler&#243;tica durante la edad f&#233;rtil, con aumento de los niveles del HDL y protecci&#243;n cardiovascular.</p>
      <p>Un aspecto interesante es que las mujeres tambi&#233;n presentaron mayor riesgo de perjuicio de calidad de vida. Esta observaci&#243;n podr&#237;a sugerir que los dos fen&#243;menos est&#225;n relacionados. Es decir, el mayor riesgo de eventos en mujeres podr&#237;a estar asociado, en parte, al hecho presentar m&#225;s s&#237;ntomas depresivos y con ajuste sicosocial m&#225;s pobre frente a un evento cardiovascular<sup>11</sup>. Sin embargo, la asociaci&#243;n entre perjuicio de la calidad de vida y desenlaces desfavorables no se evalu&#243; en el presente estudio. Esto se dio porque la ICP se llev&#243; a cabo tras la definici&#243;n de los scores, lo que podr&#237;a constituirse en sesgo de interpretaci&#243;n. A pesar de ello, merece la pena recordar las evidencias de que mujeres con menor convivio y integraci&#243;n social y s&#237;ntomas depresivos tienen mayor el riesgo de desenlaces cl&#237;nicos desfavorables en la presencia de EAC<sup>37, 38</sup>. Adem&#225;s de ello, mala calidad de vida y estr&#233;s emocional producir&#237;an disfunci&#243;n ov&#225;rica, menor secreci&#243;n estrog&#233;nica, activaci&#243;n neuroendocrina e hipercortisolem&#237;a, acelerando el proceso ateroscler&#243;tico<sup>39, 40</sup> y cerrando el ciclo vicioso.</p>
      <p>
        <bold>Conclusi&#243;n</bold>
      </p>
      <p>La calidad de vida se encuentra perjudicada en pacientes con EAC severa y estable. Este perjuicio se acepta en mujeres y pacientes con otras comorbidades, como DM, sobrepeso, obesidad, hipertensi&#243;n no controlada y evento cardiovascular o ICP previos. Doce meses tras la ICP, hubo mayor riesgo de desenlaces desfavorables en mujeres y en pacientes con evento cardiovascular previo o sin &#233;xito en el procedimiento.</p>
      <p>
        <bold>PotencialConflicto de Intereses</bold>
      </p>
      <p>Declaro no haber conflicto de intereses pertinentes.</p>
      <p>
        <bold>Fuentes de Financiaci&#243;n</bold>
      </p>
      <p>El presente estudio no tuve fuentes de financiaci&#243;n externas.</p>
      <p>
        <bold>Vinculaci&#243;n Acad&#233;mica</bold>
      </p>
      <p>No hay vinculaci&#243;n de este estudio a programas de postgrado.</p>
      <p>
        <bold>Referencias</bold>
      </p>
    </body>
  </sub-article>
</article>
